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1.1 Abstract:  
Background 
Recent studies suggest that Cognitive Behaviour Therapy (CBT) is no more effective at 
reducing negative symptoms of schizophrenia than active control groups. There have been 
mixed findings whether group interventions are effective treatment delivery methods. 
Also, sub-population identification of negative symptoms is an important consideration 
because a lack of understanding could hamper treatment. 
 
Aims 
This paper aims firstly, to determine if protocol adaptations in interventions are important 
for treatment of negative symptoms. Secondly, are CBT interventions more effective than 
control groups.   Thirdly, to identify if studies routinely screen for negative symptom 
profiles and fourth, to examine whether group interventions are an effective treatment 
method. 
  
Method 
Studies were identified by searching electronic databases and hand searching the reference 
lists of these papers.  Studies were included if they were a Randomised Control Trial, CBT 
was the main intervention design and negative symptoms were measured and reported.  
 
Results 
Eight papers were included in the final review. Specific protocol adaptations to populations 
were found to be more effective at reducing negative symptoms than active control groups. 
Only one studied identified sub-populations of negative symptoms.  Older measures of 
negative symptoms are still being employed in more recent studies, two studies employed 
a group intervention and both were found to be effective in comparison to active controls. 
 
Conclusions 
This review presents findings that suggest CBT for schizophrenia is more effective if there 
are appropriate adaptions made to the protocol e.g. considerations around negative 
symptom difficulties. In addition, studies should measure negative symptoms more 
thoroughly in patients to establish whether the improvements are in predominant or 
prominent symptom profiles.  Finally, group interventions that are adapted were found to 
be effective over groups with no adaptations. These findings suggest that adaptation of 
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CBT towards the needs of the client group may be more effective than non-adapted CBT at 
reducing negative symptoms in schizophrenia. 
1.2 Introduction 
Schizophrenia is a heterogeneous clinical syndrome comprising of several 
psychopathological domains that vary in individuals who suffer from this illness (Fusar-
Poli, Papanastasiou, Stahl, et al., 2015).  Experiences can include positive psychotic 
symptoms such as delusions, hallucinations and disorganised thoughts and behaviour. 
Some people also experience negative symptoms, which are conceptualised as a deficit or 
loss of some functions (Strauss, Carpenter, Bartko, 1974).  Although positive symptoms 
often respond to medication, negative symptoms are typically more difficult to treat.  
Indeed, negative symptoms have been described as a critical unmet need in the treatment 
of people with schizophrenia (Buchanan, 2007).  Importantly, up to 50% of patients suffer 
from negative symptoms, even 1 year after their last episode of psychosis.  Negative 
symptoms are also a key predictor of poorer quality of life and functional outcome 
(Klingberg, Wittorf, Herrlich, et al., 2009).  In essence, negative symptoms are an 
important area of research because they are identified as an unmet therapeutic need, burden 
on carers and contribute to the enormous costs of schizophrenia to health services 
(Buchanan, 2007).  
 
Negative symptoms were traditionally conceptualised as five main symptom domains: 
anhedonia, asociality, avolition affect flattening and alogia.  Crow (1980) argued that 
negative symptoms have different neuropathic origins, course and prognosis. Therefore, 
negative symptoms have been further conceptualised as two sub-groups of primary and 
secondary symptoms (Buchanan, 2007).  Primary symptoms are also described as deficit 
syndrome or predominant negative symptoms (Buchanan, 2007). Primary negative 
symptoms are not secondary to other symptoms they are intrinsic to schizophrenia.  
Secondary or prominent negative symptoms are typically described as being caused by 
other underlying mechanisms, for example positive symptoms, depression or anxiety, 
medication side effects, social deprivation and substance misuse (Stauffer, Song, Kinon, et 
al., 2012).  This difference in sub-types of negative symptoms is important because the 
same behaviour may be mediated by different psychological processes (Mcleod, Gumley 
& Schwannauer, 2015). Careful analysis of sub-type symptoms would allow for a more 
detailed understanding of whether improvements in treatment are secondary to 
improvement in positive symptoms (Stauffer et al., 2012).   It would also help 
interventions to be more targeted.  This is important because primary negative symptoms 
are associated with poorer recovery and any changes in these symptoms are unlikely to be 
	 3	
related to positive symptoms.  Whereas any changes in secondary symptoms are likely to 
be due to a reduction in positive symptoms.  The current approach to treatment 
development is to identify and try to modify specific mechanisms of disease action. For 
psychological therapy trials and CBT for psychosis in particular this issue is not well 
addressed. The majority of CBTp trials are actually CBT for voices and delusions. 
Therefore it may be important to analyse sub-patterns of symptoms and their underlying 
causes (or maintenance factors). No current reviews have done this with any rigour for 
negative symptoms. 
 
 Our evolved understanding of negative symptoms requires that instruments can accurately 
measure and identify the sub-types of negative symptoms. Accurate assessment enables 
clinicians to provide treatment goals and systematic evaluation of outcomes. The types of 
measures employed within schizophrenia research vary and Daniel (2013) reports that 
when assessing negative symptoms the evaluation of each domain is important because it 
is unknown if the underlying psychophysiology is the same or different. The Positive and 
Negative Symptom Scale (PANSS; Kay, Fiszbein, Opler, 1987) and the Scale for 
assessment of Negative Symptoms (SANS; Andreasen, 1984) are the two standard scales, 
which are recommended by the NIMH-MATRICS consensus statement (Kirkpatrick, 
Fenton, Carpenter, Marder, 2006). Factor analysis of studies employing the SANS 
(Blanchard & Cohen, 2006) have identified two clusters of negative symptoms.  The first 
is diminished emotional expression (DEE), which incorporates affect flattening and alogia.  
The second factor is diminished motivation (DM), which involves avolition-apathy and 
anhedonia-asociality.  It would seem that disturbed motivation and volition appear to exert 
a more pernicious and disabling effect than DEE. Therefore, it could be of benefit if trials 
keeping this at the forefront to ensure measurement of negative symptoms in a more 
precise way. 
 
The categorisation of people with schizophrenia into sub-populations means that 
interventions could be more tailored to the specific difficulties caused by primary 
symptoms.  Indeed, the NIMH consensus statement suggests that negative symptoms 
should be a specific treatment target and that intervention studies should be able to identify 
whether treatment effects have targeted primary or secondary negative symptoms.  
 
Due to the enduring and debilitating effects of negative symptoms, psychosocial treatments 
for negative symptoms have drawn much attention and are a high priority for intervention 
development (Buchanan, 2007).  The effects of standard medical treatments have been 
	 4	
modest (Aleman, Lincoln, Brugggeman, et al., 2016) which has stimulated attention on 
whether the prognosis for negative symptoms can be modified through psychosocial 
therapies.  A meta-analysis of biological and psychological treatments found that most 
treatments reduce negative symptoms, however, they did not meet the threshold for 
clinically significant improvement (Fusar-Poli et al., 2015).  In addition, this study 
incorporated Cognitive Behaviour Therapy (CBT), cognitive remediation and music 
therapy as one psychological intervention and then aggregated all outcomes to a single 
effect size.  Therefore, it is difficult to comment on the effectiveness of individual 
interventions (Fusar-Poli et al., 2015).  
 
Cognitive Behaviour Therapy for psychosis (CBTp) is the only psychosocial intervention 
recommended by the Patient Outcome Research Team (PORT; Dixon, Kickerson, Bellack 
et al., 2010).  Therefore, it will be widely delivered in clinical practice, and it is the most 
widely studied intervention for psychosis (Aleman, Lincoln, Bruggeman, Melle, Arends, 
Arango & Knegtering, 2016). CBTp was originally developed for positive symptoms 
however; it has also shown promise in reducing negative symptom (Grant, Huh, 
Perivoliotis, Stolar and Beck, 2011 and Klinberg, Wolwer, Engel et al., 2011).   
 
Elis, Caponigro and Kring (2013) conducted a systematic review of psychosocial 
treatments for negative symptoms of schizophrenia.  They examined the effectiveness of 
CBT and they concluded that that CBT was effective as an individual treatment but that it 
was less clear on the effectiveness with group based interventions.  They also highlighted 
that follow-up periods after the intervention was important to fully evaluate the benefits of 
CBT because the effects of treatment and skills learned persisted over time. They 
concluded that although NICE guidelines (NICE, 2009) state that CBT is the 
recommended treatment for schizophrenia they found skills-based interventions to be 
comparable in effectiveness to CBTp.   
 
A review summarising the evidence for the current treatments of negative symptoms 
(Aleman et al, 2016) was unable to find the effect sizes in more recent studies that were 
found in older generation studies.  This was also a finding in Volthort, Koeter, van der 
Gaag et al., (2015). Aleman et al. (2015) concluded that CBT requires further investigation 
due to the heterogeneity in treatment responses in particular with low functioning patients 
with moderate to severe schizophrenia. 
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More recently, Lutgens, Genevieve and Malla (2017) investigated the outcome of negative 
symptoms in psychological and psychosocial interventions and found that only two out of 
27 studies were specifically adapted for negative symptoms.   In addition, they stated that 
there was high heterogeneity between studies proving comparisons problematic.  
Differences in study characteristics included treatment length and number of sessions, 
duration, control groups and different adaptions of CBTp and measurement of negative 
symptoms.  They did report CBTp to be an effective intervention for negative symptoms, 
however, not against an active control group, concluding that perhaps any intervention is 
helpful at reducing negative symptoms.  Lutgens et al. (2017) also highlight that skills 
based interventions may have comparative utility to CBT.  
 
In summary, previous meta-analyses have shown that negative symptoms can improve 
following CBTp even if they have not been specifically targeted as part of the protocol 
(Wykes, Steel, Everitt, & Tarrier, 2008). One potential interpretation of this is that the 
negative symptoms that are responding are secondary to positive symptoms, for example, 
as delusions and hallucinations reduce, so do negative symptoms. It is not clear if studies 
routinely screen for negative symptoms profiles, this would help to identify whether the 
effects of treatment have targeted predominant or prominent negative symptoms. This is 
important because predominant negative symptoms are more pernicious, harder to reduce 
and therefore warrant attention and no one has tried to analyse the CBTp literature to 
determine if it is the patients with predominant negative symptoms who show the most 
reliable treatment effect. Heterogeneity between studies is high as many studies adapt CBT 
and it is unclear whether these protocol adaptations are a critical factor regarding 
effectiveness, and in many cases the nature of the adaptations is not clear. Groups are 
routinely run in community mental health settings due to cost effectiveness, yet it is 
unclear whether this is an effective method of intervention due to conflicting findings in 
studies. With these factors in mind, this study will update and extend the Elis et al. (2013) 
systematic review by examining treatment protocols of more recent studies due to the 
findings of Volthorst et al. (2015) and Aleman et al. (2016) that newer studies were not 
replicating the findings of older studies. Secondly, there is a need to scrutinise studies and 
describe whether there are data that can be extracted re predominant versus prominent 
negative symptom profiles.  Therefore, we will examine if negative symptoms are being 
routinely screened to identify whether patients have predominant or prominent negative 
symptoms. Finally, we will re-examine CBT as an individual treatment compared to group 
interventions, this finding was less clear in Elis et al. (2013), whereas, Volthorst et al. 
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(2015) found individual interventions more effective than group and Lutgens et al. (2017) 
found no difference between group or individual CBT for negative symptoms.  
 
 
Aim and research questions 
This systematic review has three key aims, firstly to determine what adaptations are 
implemented in CBT, how are these adaptations are described and if they have any effect 
on the outcome of negative symptoms.  Secondly, to identify if studies routinely screen for 
negative symptom profiles and thirdly to examine whether group interventions are an 
effective treatment method. 
  
The following questions guided the systematic review: 
1. Are interventions that are targeted towards negative symptoms more effective than 
those with no adaptations? 
2. Are CBT interventions more effective compared to control groups? 
3. Do studies examine primary and secondary symptom profiles of participants? 
4. Are group interventions an effective CBT treatment for negative symptoms? 
 
 
1.2 Method 
 
Search Strategy 
The literature search was carried out for the period of January 2012 to March 2017.  As 
Elis et al. (2013) have published a systematic review examining psychosocial treatments 
for negative symptoms, which included CBT we are updating and advancing this paper.   
The following on-line databases were searched: EBSCO – PsychInfo, CINAHL, 
MEDLINE and psychological and behavioural Sciences collection.  AMED, medline and 
EMBASE were searched in the OVID database as well as the Cochrane central register of 
controlled trials. 
 
For each of the databases the following search terms were utilised using the Boolean 
operator “OR”: (1) schiz* “OR” psychosis; (2) Randomised control trial “OR” RCT; (3) 
cognitive behaviour* therapy “OR” cognitive behavior* therapy; (4) negative symptoms 
“OR” symptoms of psychosis.  These searches were then combined using the Boolean 
operator “AND”.  A hand search was conducted of the Elis et al. (2013) paper and In 
addition forward citations on this paper was carried out on all the databases searching for 
any articles that referenced the systematic review.  This resulted in a total of 37 being 
	 7	
identified after the removal of duplicates.  The titles and abstracts of these articles were 
screened to determine eligibility based on the following inclusion criteria: 
 
• Adult participants (18-65) with a reported diagnosis of schizophrenia spectrum 
disorder. 
• Randomised Control Trial design  
• CBT intervention as the main treatment and focus of the RCT 
• Negative symptoms measured and reported 
 
Papers were excluded if they were not published in English, and if negative symptoms 
were not reported.  In addition, reports, review papers, conference abstracts, theses and 
unpublished studies were all excluded.   This resulted in a total of 8 papers being 
identified.  A second researcher reviewed all the papers at this point and 100% agreement 
was reached on the included papers.  Figure 1 shows the details of this process. 
 
Data extraction and quality ratings 
A data extraction sheet was used which recorded information of the following: 
• Participant characteristics 
• Nature of the CBT intervention and control group.   
• Adaptations to protocol 
• Measures of negative symptoms 
• Information regarding the change in negative symptoms seen in the treatment arm 
of the trial.  
 
Methodological rigour was assessed using the Clinical Trial Assessment Measure (CTAM; 
Tarrier & Wykes, 2004) The CTAM is a dedicated scale for assessing the quality of 
psychological treatment trials in mental health. The CTAM offers an overall assessment of 
the methodological rigour on six subscales, assessing sample size, recruitment method, 
allocation to treatment, assessment of outcome, control groups, description of treatment, 
and analysis. The CTAM total score of 65 or above was chosen by Wykes, Steel, Everitt, 
and Tarrier, (2008) to describe adequate methodology. The total scores ranged from 68 to 
97 with a mean score of 80.50 (9.70; see Appendix 10) 
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Figure 1: PRISMA diagram of study selection 
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1.3 Results 
 
Table 1 shows the results for the eight studies that tested CBT for negative symptoms of 
psychosis. The following details the results in relation to each of the specific questions 
posed by the review. 
 
CBT adaptations 
 
Granholm, Holden, Link, and McQuaid (2014) adapted CBT to include social skills 
training (CBSST) and included a goal of therapy to improve functioning of negative 
symptoms.  This was delivered as a group intervention and was a manualised approach, 
broken down into three modules (cognitive, social and problem-solving skills).  The 
intervention focused on the practice of simplified thought challenging and behavioural 
experiment activities.  Each module had a primary skill which participants were taught to 
develop. This study found no difference between groups but did find a significant 
reduction in motivation when followed up 12 months later in the CBT group. 
 
Grant, Huh, Perivoliotis, Stolar and Beck (2012) used Cognitive therapy plus standard 
treatment, delivered weekly for 18 months. This was an individual treatment plan and 
sessions were very much tailored to the needs of each individual. This involved focusing 
on their interests and strengths and defeatist beliefs.  The control group received standard 
treatment from clinicians in the community and were actively engaged in services provided 
by the local community.  Grant et al. (2012) analysed each of the SANS subscales and 
found that avolition-apathy and anhedonia-asociality (diminished motivation), were 
significantly reduced in the CT group.  
 
Two studies (Krakvik, Grawe & Stiles, 2013 and Lincoln, Ziegler, Mehl, Kesting, 
Lullmann, Westermann & Rief 2012) used a simplified version of the treatment model of 
CBTp, which was adapted by Chadwick, Birchwood and Trower (1996). Both trials aimed 
their therapy at reducing distress and challenging positive symptoms. The control group for 
both studies was treatment as usual and both studies were in clinical settings.  Both these 
studies found no difference in negative symptoms between or within groups. 
 
Lecomte, Leclerc and Wykes (2012) conducted CBT in a group setting using a manualised 
approach which was significantly adapted by the researchers.  The adaptations to the 
intervention involved breaking it down into four parts: (1) stress and how it affects me; (2) 
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testing hypotheses and looking for alternatives; (3) drugs, alcohol, and how I feel; and (4) 
coping and competence.  The manual follows a positive approach rather than problem 
based and patients learn to understand CBT.  The control group was a skills training 
groups which was manualised and involved teaching skills for symptom management and 
relapse prevention. Each group received 24 session (twice weekly), which was over a 3-
month period.  At the end of the study they found that the skills training group had the 
same reduction in negative symptoms at a 9-month follow-up. 
 
Li, Guo, Wang, Xu, Qu, Wang, Sun et al. (2015) delivered a culturally adapted CBT 
manualised CBT approach based on the principles and practice developed by Kingdom and 
Turkington (2004). The researchers made no negative symptom adaptations.  The control 
group received supportive therapy and both groups received 15 sessions over 24 weeks and 
were followed up at 19 months.  This study found a significant reduction of negative 
symptoms in both groups. 
 
Morrison, Turkington, Pyle, Spence, Brabban, Dunn, et al. (2015) conducted individual 
cognitive therapy and treatment as usual using a manualised approach that was developed 
by the researchers.  The treatment as usual group received regular monitoring and 
assessment with the PANSS which provided additional benefits to participants regarding 
the therapeutic relationship.  Participants in this study were individuals who had chosen 
not to take antipsychotic drugs and received 26 sessions on a weekly basis for a maximum 
of nine months and four booster sessions in the subsequent nine months.  This study did 
not find any reduction in negative symptoms in either group. 
 
Naeem, Saeed, Irfan, Kiran, Mehmood, Gul, et al. (2015) employed a culturally adapted 
CBT intervention following intervention guidelines by Kingdon and Turkington (1994). 
The intervention was adapted substantially to accommodate the cultural and religious 
values of the patient group. A major part of the adaptation was the involvement of a family 
member involved in each session.  A total of six sessions was delivered over a period of 
four months.  The control group in this study was treatment as usual which involved 
routine psychiatric care.  This study found a reduction in negative symptoms at the end of 
treatment only in the CBT group which was statistically significant to the control group.   
 
In summary, studies that found a reduction in negative symptoms after treatment of CBT 
were Granholm et al. (2014); Grant et al. (2012); Lecomte et al. (2012); Li et al. (2015) 
and Naeem et al. (2015). Out of those studies, only two (Grant et al. (2012) and Naeem et 
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al. (2015) found a significant difference in the CBT group compared to the control group. 
Neither of those two studies conducted a follow-up they both conducted analysis at the end 
of the intervention. 
 
Three studies Lincoln et al. (2012); Krakvik et al. (2013) and Morrison et al. (2015) found 
no reductions in negative symptoms in either the treatment group or the control group.  
Lincoln et al. (2012) and Krakvik et al. (2012) followed up at 12 months, employed a 
manualised approach and made no adaptations.  Morrison et al. (2015) did adapt the 
intervention, which lasted 18 months and conducted no follow-up. 
 
Control groups 
Three studies employed an active control group (Granholm, et al, 2014; Lecomte et al, 
2012 and Li et al, 2015).  Granholm, et al. (2014) was the only one that found a difference 
between groups.  The other two studies both found an equal reduction in negative 
symptoms. Five studies employed non-active control groups, three of those (Krakvik, et al, 
2014; Lincoln et al, 2012 and Morrison et al, 2015) did not find any reduction in negative 
symptoms for either group 
 
Negative symptoms  
 
Two studies (Granholm et al, 2014 and Grant et al, 2012) focused on negative symptoms 
as a primary outcome measure. The only study to evaluate negative symptoms on the basis 
of predominant or prominent was Grant et al. (2012) which was established by scoring 
severity of symptoms on the SANS.  Studies routinely employed diagnostic criteria to 
identify inclusion criteria and therefore negative symptoms were assessed as a secondary 
outcome measure. Table 1 shows that the most commonly employed measure of negative 
symptoms employed in four studies was the PANSS (Kay, et al., 1987).  The SANS 
(Blanchard and Cohen, 2006) was employed in three studies, and one study (Lecomte, et 
al, (2012) used the Brief Psychiatric Rating Scale (BPRS; Lukoff, Nuechterlein, & 
Ventura, 1986). 
 
Scoring on the SANS was carried out differently in each of the three studies that employed 
this measure.  Granholm et al. (2014) used the two-factor model of diminished expression 
and motivation, whereas Grant et al. (2012) analysed each of the four sub-scales within the 
measure.  Noteworthy both of those studies found an improvement in diminished 
motivation.  Karkvik et al. (2012) only reported the total score of the SANS and found no 
differences in negative symptoms in either within or between groups. 
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Group versus individual 
Two studies out of eight were group interventions (Granholm et al., 2014 and Lecomte et 
al, 2012).  Both these studies compared CBT to active control groups and followed-up at 
12 months.   Granholm et al. (2014) found that the CBT SST group had a significant 
reduction in diminished motivation; the main aim of this study was to reduce negative 
symptoms.  Whilst Lecomte et al. (2012) found that after treatment both groups had the 
same reduction in negative symptoms, but after 12 months this reduction was only 
maintained in the CBT group. 
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Table	1:		Randomised	Control	trials	of	CBT	intervention	examining	negative	symptoms	of	psychosis	
	
Studies  Participants CBT Control Treatment: 
sessions, 
duration 
(months) & 
follow-up 
NSX 
Measure 
CBT / Control     Baseline/End 
of treatment mean (SD) score  
n= participants 
Results: 
Between groups  
And NSX 
Granholm et al 
(2014) 
USA 
 
 
 
SCID diagnosis of 
SCX or SCX-A  
Duration of illness 
21 years (mean) 
Mean Age: 
CBT 41.1  
Control: 41.6 
CBT SST 
Group 
Goal: to 
improve 
functioning 
and NSX 
 
Active goal 
focused 
supportive 
contact 
 
 
 
36 + 12 booster 
9 months 
 
Follow-up at 12 
months 
PANSS total 
score 
 
SANS  
Diminished 
Motivation 
(DM) 
Expression 
(DE) 
 
CBT: n=71; n=25 
DM: 2.26 (1.11) - 1.74(0.81) 
DE: 1.82 (1.13) - 1.82 (0.96) 
 
Control: n=76; n=31 
DM: 2.11 (1.17) -2.27 (1.15) 
DE: 1.80 (1.15) -2.00 (0.96) 
 
Sig improvement  
from baseline in 
diminished 
 motivation in the 
 CBT SST group 
Grant et al (2012) 
USA 
 
 
 
 
DSM-IV diagnosis 
Low functioning 
with chronic SCX 
Prominent NSX 
using  SANS 
Mean Age: 
CBT: 34.3 (10.09) 
Control: Age: 42.9 
(10.08) 
CT + ST 
50 mins 
weekly 
Adapted 
 
Standard 
treatment (ST) 
 
 
 
12 sessions 
18 months 
 
No follow-up 
SANS  
A: avolition 
B:anhedonia 
C: affect 
flattening 
D: alogia 
 
CBT:  n=28        ST: n= 26 
A: 3.3 - 1.6         A: 3.2 – 2.8          
B: 3.4 - 2.6         B: 3.5 -3.1 
C: 2.2 - 2.9         C: 2.1 – 2.2 
D: 1.5 -1 .5         D: 1.7 – 0.7 
 
No SD reported 
Greater mean  
reduction in A and 
 B  for CBT group  
and ST group  
reduction in D  
 
Karkvik et al 
(2013) 
Norway 
ICD-10 SCX or 
SCX-A 
Residual auditory 
hallucinations and 
delusions 
experienced in last 
6 months 
Age: 35.26 (8.89) 
Age:37.5 (11.15) 
CBTp 
 
 
TAU & waitlist 
 
 
20 sessions 
6 months 
 
follow up at 12 
months 
SANS (only 
total score) 
 
CBT:  
6.48 (3.0) n=23 
6.3 (3.32) n=13 
 
Control     
8.09 (4.26) n=22 
8.14 (3.54) n=15 
 
No difference 
Between groups 
 and no sig  
difference  
in NSX at the  
 
end of treatment. 
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Table	1	Cont’d:		Randomised	Control	trials	of	CBT	intervention	examining	negative	symptoms	of	psychosis	
	
Studies  Participants CBT Control Treatment: 
sessions, 
duration 
(months) & 
follow-up 
NSX 
Measure 
CBT / Control     
Baseline/End of treatment 
mean (SD) score 
 
n = participants 
Results: 
Between groups 
and 
NSX 
Lecomte et 
al (2008) 
 
 
 
 
 
 
 
Lecomte et 
al (2012) 
Canada 
 
Recent onset 
psychosis 
Recently 
discharged from 
hospital some had 
unclear diagnosis; 
SCX spectrum 
and mood 
disorder with 
psychotic 
features. 
Age CBT: 24.92 
TAU: 23.10 
 
CBT group 
Manual adapted by 
study researchers 
 
 
Skills trg (SM 
group) 
Age: 25.44 
 
TAU + waitlist 
 
 
 
24  (2x weekly) 
3 months 
 
9 months follow-
up 
 
 
 
 
 
12 month follow-
up 
BPRS (neg) 
 
CBT (study only reported CI) 
1.9 CI (1.5-2.2) n=48 
1.4 CI (1.2-1.7) n=35 
SM 
1.9 CI (1.4-2.3) n=54 
1.4 CI (1.2-1.7) n=17 
Control 
1.6 CI (1.2-1.9) n=27 
1.5 CI (1.1-1.9) n=13 
 
CBT: 1.37 (0.8) n=14 
 
At 9 months the 
skills trg group had 
the same reduction 
in NSX as the CBT 
group. 
 
 
 
 
NSX maintained at 
12 month for CBT 
group but not for 
the skills group. 
Li et al 
(2015) 
China 
SCID for SCX 
PANSS total 
score > 60 = mild 
level of 
psychiatric 
symptoms 
Age CBT : 
29.27 (8.36) 
TAU: 33.44 
(9.51) 
CBT (CA) 
Individual 
Manual 
 
 
 
Supportive therapy 
(individualised 
psychotherapy) 
12 sessions in 12 
weeks 
 
12 sessions over 3 
months + 3 
booster in 
subsequent 12 
weeks. 
 
19 month follow-
up 
PANSS 
NEG 
 
CBT 
19.99 (5.96) n=96 
14.01 (5.18) n=85 
 
Control 
20.80 (5.66) n=96 
16.24 (6.4) n=82 
No sig difference 
between groups 
Reduction in both 
groups for NSX 
 
	
SCX:	schizophrenia;	SCX-A:	schizoaffective	disorder;	NSX:	negative	symptoms;	TAU:	treatment	as	usual;	ETAU:	enhanced	treatment	as	usual;	SCID:	structured	clinical	
interview	for	the	Diagnostic	and	Statistical	Manual	of	Mental	Disorders,	fourth	edition;	CBTp:	Cognitive	behaviour	therapy	for	psychosis;	CBT	(CA):	culturally	adapted;	
CT:	cognitive	Therapy;	SANS:	Scale	for	assessment	of	negative	symptoms;	PANSS	NEG:		Psychotic	and	negative	symptom	scale;		
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Table	1	Cont’d:		Randomised	Control	trials	of	CBT	intervention	examining	negative	symptoms	of	psychosis	
	
Studies  Participants CBT Control Treatment: 
sessions, 
duration 
(months) & 
follow-up 
NSX 
Measure 
CBT / Control     Baseline/End 
of treatment mean (SD) score  
 
n= participants 
Results: 
Between groups 
 And NSX 
Lincoln et al (2012) 
Germany 
 
 
Diagnosis of 
SCX or SCX-A 
or delusional 
disorder or brief 
psychotic 
disorder 
CBTp 
Individual 
 
Age: 32.2 
(10.4) 
TAU & 
waitlist 
Standard 
psychiatric 
care twice 
over 4 
months 
Age: 33.1 
(10.9) 
4-5 sessions 
45 months 
 
12 month 
follow-up 
 
 
PANSS 
NEG 
 
CBT 
14.9 (4.6) n=40 
14.5 (4.6) n=40 
Control 
13.4 (4.6) n=40 
12.9 (3.4) n=40 
No difference  
between groups 
No sig diff in NSX  
Morrison et al (2015) 
UK 
ICD-10 
diagnosis of 
SCX, SCX-A or 
delusional 
disorder 
Not taking 
psychotic drugs 
 
CT + TAU 
Individual 
60min 
TAU 
(no details) 
26 + 4 booster 
18 months 
No follow-up 
 
PANSS 
NEG 
 
CBT: 
13.54 (3.17) n=28 
12.53 (16.59) n=17 
Control: 
14.88(5.77) n=24 
16.59(6.65) n=17 
 
 
CBT had no effect 
 on NSX on either 
group.  
Naeem et al (2015) 
Pakistan 
 
 
 
Diagnosis of 
SCX or a related 
disorder 
according to 
ICD10 
Duration TAU: 
4.7 and CBTp: 
5.8 years 
Age: 59 (31.7) 
Age: 57 (31.1) 
CBT (CA) 
Individual 
 
 
 
 
TAU 
Routine 
psychiatric 
care 
 
 
6 sessions 
4 months 
No follow-up 
 
 
PANSS 
NEG 
 
CBT: 
14.7 (3.7) n = 59 
11.2 (3.5) n=53 
 
Control: 
14.4 (3.4) n=57 
14.8 (4.9) n-49 
 
No sig difference 
 in NSX at baseline  
but Sig diff between 
groups at end of  
trial. Reduction in  
NSX only in CBTp 
group. 
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1.5 Discussion 
This review found that five out of the eight studies developed their own CBT protocol.  
Two of those studies had active control groups and both reported reductions in negative 
symptoms for the CBT group.  The other three studies compared against treatment as usual 
and two found a reduction of negative symptoms in the CBT group. Significantly, the only 
study that did make adaptions and found no change to negative symptoms was where the 
patients were not taking any psychotic medication (Morrison et al., 2015).  Three studies 
followed the CBTp manual by Kingdom and Turkington (2004) and all three studies 
employed treatment as usual for the control group.  None of those studies found a 
reduction in negative symptoms in either group. Only one study (Grant et al., 2012) 
assessed patients for negative symptoms types and six studies measured negative 
symptoms Finally two studies delivered group interventions and both those studies 
employed active control groups and both found a reduction in negative symptoms in the 
CBT group. 
 
CBT protocol adaptations 
Our findings suggest that if adapted appropriately for the target population then CBT is an 
effective intervention for reducing negative symptoms of schizophrenia.  Nevertheless, all 
the study adaptations were different and therefore it is not possible to evaluate successful 
ingredients of the interventions.  Heterogeneity is frequently cited as a common issue in 
these studies (Lutgens, et al., 2017), however, rather than focus on treatment length or 
patient characteristics we felt it would be more fruitful to establish if adaptions were an 
important factor.  Two studies (Granholm et al., 2014 and Grant et al., 2012) made 
adaptations that were behavioural and directed attention towards abilities, focusing on 
what one could do.  The results of these studies both found improvement in motivation, 
which could indicate that a positive orientation coupled with support in practical skills, are 
key adaptations to CBT for negative symptoms.  Recognising the importance of culture 
appears to also be an important consideration when adapting CBT for negative symptoms.  
Naeem et al. (2015) adapted their intervention significantly to accommodate cultural 
beliefs, however, treatment was only six sessions over four months, yet they found a 
significant reduction in negative symptoms.  The researchers employed the PANSS 
negative symptom scale which is limited in the information that it provides therefore it is 
difficult to say what mechanisms were important adaptations. Importantly, Morrison et al. 
(2015) recruited patients who were not taking any anti-psychotic medication and found no 
reduction in negative symptoms.  The adaptations to the intervention were not explicit,  
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however, it may be that anti-psychotic medication is an important factor in the treatment of 
negative symptoms. 
 
Elis et al. (2013) suggested that active controls could be as effective as CBT for reducing 
negative symptoms.  Our findings suggest that an adapted intervention is more effective 
than active control, however due to the small number of studies in this review it is difficult 
to say with any certainty. 
 
Ways of Assessing and Analysing Negative symptoms 
Only one study (Grant et al., 2012) in this review assessed patients for negative symptom 
profiles during recruitment eligibility.  They employed the SANS to identify prominent 
negative symptoms and adapted CBT to specifically target prominent symptoms and found 
a reduction in avolition/apathy. Granhom et al. (2014) also employed the SANS as an 
outcome measure, and reported the two-factors of diminished motivation and expression.  
The PANSS was the most commonly used instrument to measure negative symptoms (four 
out of eight studies).  A major limitation with the PANSS is that it only has seven items to 
measure negative symptoms and is not designed to rate negative symptoms exclusively 
(Marder and Kirkpatrick, 2014).  Although recommended as a valid and reliable measure 
by the NIMH-MATRICS consensus statement (Kirkpartrick et al., 2006) the advances in 
the description of negative symptoms require more updated measures for example the 
Clinical Assessment Interview for Negative Symptoms (CAINS) to address some of the 
shortcomings.  In addition, the SANS and the PANS have been described as out-dated 
measures (Velthorst et al., 2015) and differ in the domains that they measure which makes 
comparison across studies difficult.   
  
In summary this review found only two studies that examined negative symptoms profiles 
in patients.  It would seem that diminished motivation shows more capacity for change in 
interventions, however, as the majority of studies employ the PANSS negative subscale to 
assess for changes in negative symptoms it is not possible to evaluate this fully.  Therefore, 
studies are not routinely employing newer recommended measures for negative symptoms 
such as the CAINS and this is important enable clinicians to accurately measure changes in 
negative symptoms.  
 
Group studies 
Group CBT was delivered by two studies and both found a reduction in negative 
symptoms. Both of these studies compared CBT that was adapted for negative symptoms 
and compared them to an active control.  Whilst no conclusions can be made from the 
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small number it is interesting that compared to active controls these studies found CBT to 
be more effective.  Elis et al. (2013) reported on five group intervention studies, three of 
those found improvements but two of those were not above the active control.   
Although the low numbers means that we cannot say anything conclusive, it would seem 
with adaptations CBT can be effective as a group intervention  
 
Future considerations 
In order to establish the effectiveness of CBT intervention for negative symptoms future 
studies should consider how they measure negative symptoms.  It would seem that by 
identifying whether patients are experiencing predominant or prominent symptoms is 
helpful to establish which type of negative symptoms there has been a reduction in.  This is 
important because a lack of understanding of negative symptoms can hamper treatment 
and if we can accurately identify sub-populations then treatment programmes can be more 
tailored.   
 
Conclusion 
The results of this review extend previous reviews by examining more recent studies; 
focusing on CBT intervention protocol; examining if negative symptom profiles are 
considered as part of the recruitment criteria and extending our understanding of group 
CBT.  Our findings would suggest that tailoring treatment to the individually relevant 
factors that are identified is likely to lead to better treatment results 
an intervention towards negative symptoms and the needs of the population could be an 
important factor the effectiveness of CBT for negative symptoms of schizophrenia.  In 
addition, studies are not employing the recommended measures for negative symptoms.  It 
is important for clinicians to identify whether changes in negative symptoms are 
predominant or prominent as often changes are as a result of a reduction in positive 
symptoms or improvements in mood.  Finally, only two studies were group interventions 
and both those studies found a reduction in negative symptoms compared to active 
controls.  We cannot say with certainty but this does suggest that group intervention is 
effective method to deliver CBT for individuals with schizophrenia.  
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2.1 Plain English Summary 
 
Title  
How social problem-solving, meta-cognition and autobiographical memory differ in 
negative subtypes of psychosis. 
 
Background 
Negative symptoms are characterized by a loss of normal functioning and as a result can 
have a bigger impact on life, for example individuals may have less social contact and be 
involved in less pleasurable activities.  Negative symptoms show less improvement with 
medication.  Therefore there is a need to explore alternative treatments such as 
psychosocial therapies. 
  
Social problem-solving involves actions and thoughts about how to deal with everyday 
problems of ourselves and others.  Difficulties with social problem-solving is common in 
individuals who experience negative symptoms of psychosis.  We are now beginning to 
understand that part of the difficulty involves thinking about thinking (meta-cognition). 
We also know that psychological therapies do help with the negative symptoms of 
schizophrenia but for them to be more effective we need to understand more about the sub-
groups of negative symptoms. Therefore, the more we know about all these factors that 
have a negative impact on the quality of someone’s life the more we can adapt 
psychological therapies to try and improve their quality of life. 
 
Aims and Questions 
This study aimed to examine how negative symptoms experienced by people with 
schizophrenia interact with meta-cognitive and social problem-solving deficits.  
Specific research questions include: (i) what is the nature of the relationship between social 
problem solving and the negative symptoms of schizophrenia? (ii) Do individuals with 
predominant negative symptoms exhibit more difficulties with meta-cognition and social 
problem-solving than those with higher levels of positive symptoms of psychosis?   
 
Methods 
We recruited inpatients from mental health wards across NHS Greater Glasgow and Clyde. 
Each participant met with the researcher once. Participants completed questionnaires 
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measuring mood, social problem-solving and about their negative symptoms. Participants 
then completed two tasks, one about social problem-solving and another where they were 
asked questions about their life. 
 
Main Findings and Conclusions 
We found that if individuals with a diagnosis of schizophrenia have good problem-solving 
skills and view problems positively, then they reported lower negative symptoms of 
avolition and apathy.  We also found that mastery, a dimension of meta-cognition was 
positively associated with actual problem-solving performance.  These findings help show 
support for the importance of social problem-solving skills interventions in relation to the 
treatment of negative symptoms of schizophrenia. 
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2.2 Abstract 
Background 
Negative symptoms in schizophrenia are an important area of research due to their 
relationship with reduced quality of life. Interventions targeting defeatist beliefs have been 
found to improve negative symptoms, which are also associated with poor meta-cognition 
and autobiographical memory.   Understanding metacognition may help us to understand 
the processes that affect social problem-solving (SPS) and negative symptoms, and 
together this information may help focus newer, more effective interventions. 
Aims 
The aims of this study were to examine how negative symptoms experienced by people 
with schizophrenia interact with meta-cognitive, autobiographical memory and social 
problem-solving deficits.  
Method 
This was a cross-sectional study of 14 inpatients from the community mental health 
inpatient and forensic directorate wards across GG&C who had a diagnosis of 
schizophrenia and were experiencing difficulties with negative symptoms.  Participants 
were asked to complete measures of social problem-solving, mood and negative 
symptoms.  They were then asked to complete four social problem-solving scenarios, then 
asked questions about their life using the Indiana Psychiatric Illness Inventory (IPII) and 
finally they were presented with the AM task which consisted of 15 words and each 
required the participant to attribute the word to a specific memory. Finally, participants 
were categorized into predominant or prominent symptom profiles for comparison between 
groups. 
Results 
Participants were found to have lower levels of avolition and alogia if they have a positive 
orientation to solving problems and are able to consider various options when trying to 
solve a problem.  In addition the meta-cognition subscale of mastery was positively related 
to actual problem-solving performance and effectiveness. 
Conclusion 
Post hoc analysis found that the negative symptoms of avolition and alogia are positively 
associated with the functional problem-solving constructs of rational problem-solving and 
positive problem orientation. Whilst this study experienced major methodological 
limitations the findings could guide future studies to focus on attitudes and actual problem-
solving ability, which could be important factors in relation to interventions for negative 
symptoms. 
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2.3 Introduction 
 
The negative symptom profiles in people diagnosed with schizophrenia can be divided into 
a predominant pattern (only negative symptoms present) and prominent profiles (marked 
by the presence of both positive and negative symptoms; Carpenter, Heinrichs, Wagman, 
1998). Negative symptoms are therefore are not a unitary domain and different sub-types 
require different approaches to treatment (McLeod, Gumley and Schwannauer, 2014).  The 
original five-factor model (Blanchard & Cohen, 2006) can be parsimoniously explained by 
two factors: diminished emotional expression (which includes blunted affect and alogia) 
and diminished motivation (avolition, anhedonia, asociality and apathy).  It is the later that 
are more disabling and pernicious and by their nature these negative symptoms are 
associated with impairments in social functioning and deficits in social problem-solving. 
(Hooley, 2010). 
 
A recent meta-analysis (Lutgens, Gariepy & Malla, 2017) suggests that there are possible 
benefits of CBT for negative symptoms; however, little is understood about the 
mechanisms of change. In one of a few RCTs for negative symptoms, Grant, Huh, 
Perivoliotis, Stolar and Beck (2011) found a reduction in avolition-apathy in the treatment 
group.  They adapted CBT to accommodate difficulties related to low functioning and 
aimed it at factors which impede goal attainment, one such factor being defeatist beliefs (If 
you cannot do something well, there is little point doing it at all). Their findings are 
consistent with demonstrated associations between negative symptoms and defeatist beliefs 
(Grant & Beck, 2009).  There are similarities between the construct of defeatist beliefs and 
negative problem orientation (NPO), which is described as viewing problems with a threat 
to wellbeing and doubting one’s own ability to solve problems successfully.  This negative 
orientation can adversely affect the initial cognitive stage of social problem-solving 
(D’Zurilla & Goldfried, 1971).  Studies have found NPO to be positively associated with 
mood finding an effect size of .47 (D’Zurilla, Nezu & Maydeu, 2002) and .55 (Miller, 
O’Carroll and O’Connor, unpublished thesis).  Therefore, if NPO is a similar construct to 
defeatist beliefs it would suggest that it could also be associated with negative symptoms 
of schizophrenia as well as poor social functioning. 
 
D’Zurilla & Goldfried (1971) consider social problem-solving to be a cognitive 
behavioural process and a vital skill needed to prosper in society as such it is an important 
factor in behavioural adjustment. Their model of social problem-solving was not 
formulated for severe psychiatric conditions, however it would seem that that the 
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characterisation of social problem-solving as a key contributor to psychological wellbeing 
is also relevant to individuals with a diagnosis of schizophrenia (Morris, Bellack & 
Tenhula, 2004). Individuals with schizophrenia have been found to have deficits in social 
problem-solving (Hatahita-Wong, Smith, Silverstein, Hull and Wilson, 2002). Importantly, 
Revheim, Schechter, Kim, et al. (2006) found that social problem-solving ability is 
negatively associated with negative symptoms of psychosis.  These findings help to 
explain why individuals who experience negative symptoms of schizophrenia are more 
likely to be socially isolated, and experience communication difficulties. Social problem-
solving has also been found to be affected by other factors which include mood and 
autobiographical memory (AM; Goddard, Dritschel, & Burton, 1996). 
 
Individuals with schizophrenia have been found to have deficits in both autobiographical 
memory (Wood, Brewin & McLeod, 2006) and social problem-solving (Morris et al, 
2004). Studies have shown that social problem-solving is closely linked to 
autobiographical memory ability (Goddard, et al., 1996). Further to this, neuroscience 
research using brain-imaging studies, suggests that there is a link in brain areas that 
support both autobiographical memory and meta-cognitive functions (Dimaggio, 
Salvatore, Poplolo & Lysaker, 2012).  This link in brain structures therefore means that 
these two cognitive functions support each other and that disruption in one could lead to 
disruption in the other. It would seem reasonable to suggest that social problem-solving is 
also connected with these same brain structures.  
 
Difficulties with meta-cognition are more pronounced in individuals with schizophrenia 
and they have been found to be associated with negative symptoms (Dimaggio, et al., 
2012).  Meta-cognitive capacities include the ability to shift back and forward from ones 
own perspective to that of others (Lysaker & Dimaggio, 2014). In other words this 
capacity allows us to form meanings, which are crucial in sustaining connections with 
family and friends as well as the community.  A greater impairment in metacognition 
suggests that individuals may experience a more disabling form of psychosis, which will 
impact more on predominant negative symptoms, regardless of positive symptoms 
reduction.  This would also suggest that meta-cognitive capacities are key to effective 
social problem-solving.  Therefore, the utility in measuring one’s meta-cognitive capacity 
could help elucidate the impact of meta-cognition on social problem-solving ability and 
AM.  
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The constructs of meta-cognition, defeatist beliefs and negative problem orientation are 
import concepts that warrant clear definitions regarding how they are conceptualized 
within this study.  Firstly, metacognition is defined by Lysaker and Dimaggio (2014) as the 
ability to understand that others have thoughts and be able to reflect on one’s own 
thoughts.  Therefore, understanding that one has their own perspective of a situation and 
another has their perspective provides insight that each individual can have different 
perspectives of the same situation. Meta-cognition is a vital social communication tool, 
which allows humans to sustain relations and solve interpersonal difficulties.  In relation to 
individuals who experience difficulties with psychosis, the greater the impairment in meta-
cognition the more difficulty an individual will experience in sustaining interpersonal 
relationships and having awareness that their thoughts may not necessarily be accurate. 
 
Negative problem orientation (NPO) is a dysfunctional or inhibitive cognitive-emotional 
set that involves a general tendency to (i) view a problem as a significant threat to well-
being, (ii) doubt one’s personal ability to solve problems successfully (low self-efficacy), 
and (iii) become frustrated and upset when confronted with problems in living (low 
frustration and tolerance; D’Zurilla et al, 2002).  Grant and Beck (2009) operationalise 
defeatist beliefs employing the Dysfunctional Attitude Scale (DAS; Weissman, 1978) 
which overgeneralizes conclusions about one’s ability to perform tasks for example, if I 
cannot do something well there is little point in doing it at all.  Therefore, it is suggested 
that defeatist beliefs and NPO are similar because by doubting one’s ability to do be able 
to solve a problem is a similar cognitive style to a belief that there is no point in trying to 
do something if it cannot be done well. 
 
In summary, psychological interventions may be promising treatments for decreasing the 
negative symptoms of schizophrenia (Elis, et al., 2013). Although untested to date, it can 
be argued that defeatist beliefs impair social functioning in a similar way to negative 
problem orientation (NPO).  Meta-cognition is key to understanding the minds of others 
and the meaning of their communication, this could help to explain the difficulties in social 
problem-solving and negative symptom in particular predominant negative symptom 
profiles.  Therefore this study examines the link between social problem-solving, NPO, 
negative symptoms of schizophrenia, meta-cognition and AM. Exploratory examination of 
these cognitive processes will help identify effective modifiable processes for intervention 
programmes. 
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Aims and research questions 
This is an innovative but early stage study that aims to explore how the development or 
maintenance of negative symptoms might be affected by social problem-solving, meta-
cognition and AM. 
 
Specific research questions include: (i) what is the nature of the relationship between social 
problem solving and the negative symptoms of schizophrenia? (ii) Do individuals with 
predominant negative symptoms exhibit more deficits in meta-cognition and social 
problem-solving than those with higher levels of positive symptoms of psychosis?  (iii) Is 
there a positive association between negative symptoms and negative problem orientation 
(NPO) and is this similar in magnitude to the correlations previously observed between 
depression and NPO? 
 
Main Study hypothesis 
(i) We expect there to be a positive correlation between negative problem 
orientation and the negative symptoms of schizophrenia.  
 
Exploratory hypotheses 
(ii) Individuals with predominant symptoms will be poorer at social problem-solving than 
those with prominent negative symptoms. 
(iii) We predict that individuals with predominant negative symptoms will have poorer 
meta-cognitive abilities than those with prominent negative symptoms. 
 
 
 
2.4 Method 
 
Participants 
 
Inpatient participants who met the DSM-5 criteria for a diagnosis of schizophrenia were 
recruited from Greater Glasgow and Clyde (GG&C) NHS mental health wards and 
Forensic directorates.  Eligible participants had to be at least 18 years of age, capable of 
providing informed consent, had a diagnosis of schizophrenia and were experiencing 
difficulties with negative symptoms. Exclusion criteria included a documented or self-
reported history of traumatic brain injury or learning disability, inability to provide 
informed consent, and insufficient command of the English language to allow meaningful 
participation.  
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Recruitment 
RMOs, psychologists and nursing staff were approached to identify and refer eligible 
inpatients, from Rowanbank medium secure unit, Leverndale low secure unit, Gartnaval 
Royal Hospital (Clyde and Kelvin wards) and Leverndale hospital (rehabilitation ward and 
ward 2).  Once identified, a staff member discussed the project with the service user, 
provided them with an information sheet (see Appendix 7) and gained verbal consent for 
the researcher to make contact.  When the researcher met with the participant written 
informed consent was obtained prior to participant taking part in the research (Appendix 
8).  
 
Sample size 
Negative symptoms are a major clinical challenge, which are marked by difficulties with 
meeting life’s challenges.  This may be due to problem orientation as we know from 
depression studies that negative problem orientation and symptom severity are positively 
correlated. Therefore, we used the literature to estimate effect sizes for our current study.  
The power analysis is focused on negative symptoms of schizophrenia and the relationship 
to problem orientation. A power analysis was conducted using G* power 3 (Faul et al; 
2007) with a medium effect size of .60, alpha set at .05 and a power of .8 this yielded a 
sample size of 13 for the correlational analysis.  The medium effect size was calculated by 
averaging the correlations from two studies (D’Zurilla, Nezu, Maydeu-Olivares, 2002 and 
Miller, O’Carroll & O’ Connor, unpublished thesis) 
 
 
Measures 
 
Negative symptoms 
 
The Self-evaluation of Negative symptoms (SNS; Dollfus, Mach & Morello, 2014) is a 20 
item self-report measure of negative symptoms of schizophrenia.  It assesses experiences 
and feelings based on the previous week. Statements are scored 2 (strongly agree), 1 
(somewhat agree) or 0 (strongly disagree). The sum of all items provides a severity of 
negative symptoms score ranging from 0 (no symptoms) to 40 (severe symptoms). 
 
The SNS is comprised of five sub-scales (social withdrawal, diminished emotional range, 
avolition, anhedonia, and alogia), presenting 5 sub-scores derived from the sum of 4 items 
each: social withdrawal; diminished emotional range; avolition; anhedonia and alogia. 
Dollfus et al, (2015) have found the scale to be a reliable and valid measure of negative 
symptoms.  Internal consistency (Cronbach’s α) in this sample was .90 for the total score; 
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social withdrawal α = .90; diminished emotional expression: α = .75; avolition: α = .76; 
anhedonia: α = .90 and alogia: α =. 78. 
 
Depression 
The Beck Depression Inventory (BDI-II; Beck, Steer & Brown, 1996) was used as a self-
report measure of depression.  This is a 21 question self-report inventory; each item has 
four possible responses and each answer can be scored on a value of 0 to 3.  Each of the 21 
items on the scale measures how an individual has been feeling in the last two weeks. The 
sum of all items indicates the severity of depressive symptoms with a maximum possible 
score of 63. This measure is widely used, it has been found to yield internally consistent 
and valid scores and has good construct validity (Dozois, Dobson & Ahnberg, 1998; 
Schotte, Maes, Cluydts, DeDoncker, & Cosyns, 1997). Internal consistency (Cronbach’s α) 
in this sample was .74. 
 
Social Problem-Solving 
The Social Problem-Solving Inventory–Revised: Short Form (SPSI-R: SF; D’Zurilla, Nezu 
& Maydeu-Olivares, 2002) is a 25-item self-report questionnaire with five sub-scales each 
of which is designed to tap into one of the five constructs that form the theoretical model 
of social problem-solving (D’Zurilla & Nezu, 1999). Those subscales are: Positive 
Problem Orientation (PPO; e.g. ‘Whenever I have a problem I believe it can be solved’); 
Negative Problem Orientation (NPO; e.g. ‘I feel threatened and afraid when I have an 
important problem to solve’); Rational Problem Solving (RPS; e.g. ‘When I have a 
decision to make, I try to predict the positive and negative consequences of each option’); 
Impulsivity/ Carelessness Style (ICS; e.g. ‘When I am trying to solve a problem I go for 
the first good idea that comes to mind’) and Avoidance Style (AS; e.g. ‘I wait to see if a 
problem will resolve itself first, before trying to solve it myself’).  Items were designed to 
reflect cognitive, affective or behavioural responses to real-life social problem-solving 
situations. Participants are asked to rate the extent to which each statement is true on a 
five-point Likert-type scale (0 = not at all true of me to 4 = extremely true of me). The 
reliability and validity of the scale has previously been demonstrated (Hawkins, Sofronoff 
& Sheffield, 2008; D’Zurilla et al., 2002).  Internal consistency (Cronbach’s α) in this 
sample was PPO:  α = .68; NPO: α = .68; RPS: α = .82; ICS:  α = .59 and AS: α = .65.  
According to the internal consistency data reported in D’Zurilla et al. (2002) these 
coefficients are lower than expected for PPO; NPO; ICS and AS. 
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The Means End Problem-solving task (Platt & Spivack, 1975) was used to assess actual 
problem-solving performance.  The version employed was a revised version of the original 
(MEPS-R; Miller, et al., Unpublished Thesis) whereby the original ten scenarios were 
adapted for today’s society and four were identified as appropriate for this population. 
 
Participants were informed that four scenarios would be read aloud to them; in addition 
they were shown a card with each scenario written on it.  Participants were advised that 
each scenario would include a problem to be solved and that they would also be provided 
with the ending to the problem.   Participants were required to describe the best way to 
solve the problem, in other words they must connect together the beginning and the end of 
each of the scenarios, providing the ‘ideal strategy’ to solving the problem (Marx, et al., 
1992).  Participant responses were audio recorded and written verbatim by the researcher.  
The four scenarios were randomised using a web-based randomizer programme to allocate 
the order in which the scenarios were presented to each participant. The order of scenarios 
was transferred to an excel sheet to identify order for each participant. 
 
Two dependent variables were derived from each of the MEPS-R scenarios, overall 
effectiveness and relevant mean steps (Williams, Barnhofer, Crane & Beck, 2005). 
Relevant means (active problem-solving steps) were scored using a coding framework 
which provides details on how to score each scenario (see Appendix 9). The total number 
of categories (mean steps) was totaled for each participant per scenario, then the scores for 
each participant’s four scenarios were totaled which gave each participant a total relevant 
means score across all four scenarios. Scoring involved summing the scores relevant 
means (α = .81). 
 
Effectiveness was defined according to the definition of an effective problem solution 
provided by D’Zurilla and Goldfried (1971). Following this definition a problem solving-
solving strategy is deemed to be effective if it maximizes positive short and long-term 
consequences and minimizes negative (short and long-term) consequences, both personally 
and socially. The overall effectiveness of each strategy was rated on a 7-point Likert-type 
scale ranging from “1 - not at all effective” to “7 - extremely effective”.  Scores were then 
totaled for each participant on all four scenarios. This method of scoring was the same as 
detailed by Williams, et al. (2005). Cronbach alpha for effectiveness was α = .79. 
 
Transcripts were rated by two independent raters, consistency between raters was 
established on a sample of 50% of the cases yielding coefficients (Cohen, 1960) of kappa 
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.90, p < .001 for number of relevant means and  Kappa (.75), p <.001 for ratings of 
effectiveness, both of which are viewed as very good and good (Landis & Koch, 1977).   
 
Autobiographical memory 
The Autobiographical Memory Test (Williams and Broadbent, 1986) is based on classic 
memory cueing paradigms. Participants are asked to report a specific memory detailing a 
personally experienced event that can be located in time and place in response to positive 
(happy, safe, interested, successful and surprised), negative (sorry, angry, clumsy, hurt and 
lonely) and neutrally cued words (grass; gigantic; absence; wildlife and bread). The words 
are presented in a fixed randomized order.  The cue words were taken from previous 
studies using this paradigm (Wood, Williams & Ferrier, 2006).  The participants were 
presented with each word verbally and visually and were asked ‘can you tell me of 
something that has happened to you that you are reminded of when you see the word ….?’. 
When it was not clear whether the initial response referred to a specific event the 
researcher provided the standard prompt: ‘Can you think of a particular time’. 
A response was coded ‘specific’ if it was a single personally experienced event, located in 
time and place and lasting no more than a day in duration.  Overgeneral responses were 
coded as either ‘categoric’ (multiple occurrences of the same event) or ‘extended’ (a single 
event lasting more than one day and having a definite beginning and end), ‘association’ if 
the response was not a memory but related to the word. Kaney. et al (1999) included a 
further category of ‘uninterpretable’, which was used if any responses that did not qualify 
as the recall of a memory or the participant was unable to recall a memory. 
 
Transcripts were rated by two independent raters, consistency between raters was 
established on a sample of 50% of the cases yielding coefficients (Cohen, 1960) of kappa 
.74, p < .001, which is viewed good (Landis & Koch, 1977).   
 
 
Indiana Psychiatric Illness Interview (Lysaker, 2002) 
This is a semi-structured interview developed to assess narratives of illness experience in 
people with psychosis and other severe and/or enduring conditions. The first part of the 
interview is spent establishing rapport and the interview style is conversational in nature 
with minimal input or direction from the interviewer. Four main areas are examined: the 
life story of the participant; how they understand their illness; how their illness “controls” 
their life and how they control it; and what they expect for the future. The interviewer does 
not ask questions about specific symptoms but may ask for clarification and further 
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information. 
 
Metacognition Assessment Scale-Abbreviated (MAS-A; Lysaker et al., 2005) 
This has been adapted for specific use with the IPII from the original MAS (Semerari et 
al., 2003), which was created to assess for metacognitive changes in therapy transcripts. 
The transcript of the IPII provides the source material for rating metacognitive ability. It 
focuses on four areas reflecting each of the MAS subscales: the participant’s “self 
reflectivity” (their understanding of their own mind), their “understanding of other’s 
minds”, “decentration” (the ability to consider the world from other perspectives) and 
“mastery” (using mental state to solve problems). Each subcomponent has a separate 
hierarchical scale and a participant is awarded one point for each step on the scale that they 
achieve. 
 
Primary MAS-A ratings were provided in the United States by the team of the MAS-A 
authors to ensure rigour.  30% of transcripts were double rated to ensure reliability.   The 
inter-rater reliability for the raters of the responses yielded coefficients of (Cohen, 1960), 
kappa .78, p <. 001, which is viewed as good (Landis & Koch, 1977).   
 
Predominant and prominent negative symptoms 
Predominant and prominent negative symptoms were operationalized using the constructs 
as defined by Buchanan (2007). Predominant or primary negative symptoms of 
schizophrenia are intrinsic to schizophrenia, are independent of any other biological or 
environmental factors and are unrelated to positive symptoms. Prominent or secondary 
negative symptoms occur in association with or are caused by positive symptoms.  In 
addition, they can be caused by medication side effects or other treatment and illness 
related factors.  During recruitment clinicians were asked to identify which category of 
negative symptoms the participant was experiencing difficulties with using the 
aforementioned definitions. 
 
 
Research Procedures 
 
After signing the consent form participants were presented with a questionnaire packet, 
which included the SPSI-R, BDI and SNS. The next task (MEPS) required participants to 
solve four problem scenarios. Participants were asked to generate a specific memory 
(AMT) detailing an event in relation to 15 words, which were presented in a randomized 
order. The last procedure was the IPII, which required the participant to respond to open 
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ended questions that asked about their lives and experiences of their illness. The whole 
procedure lasted an average of 50 minutes (range 40 to 65 mins). 
 
Data analysis 
It was planned that data cleaning would be carried out to check for missing values and 
outliers.  SPSS 22 would be used to run descriptive and correlation analysis.  Due to the 
small sample size non-parametric tests would be used. Spearman’s rho correlational 
analysis would be run to test for the main effect of the relationship between negative 
symptoms of schizophrenia and negative problem orientation. The sample would then be 
split into type of negative symptoms participants were experiencing (predominant or 
prominent) to investigate differences in scores.  
 
Post hoc analysis  
In order to ascertain if there would be a relationship between social problem-solving, meta-
cognition, autobiographical memory and negative symptoms of schizophrenia, Spearman’s 
rho correlational analysis would be calculated. 
 
Ethics 
Multi-site ethical approval was provided by South East Scotland Research Ethics 
Committee (see Appendix 6).  Approval was also gained by NHS Greater Glasgow and 
Clyde’s respective Research and Development Departments (See Appendix 4) and the 
Forensic Directorate Ethics Committee (see Appendix 5). 
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2.5 Results 
Demographic Information 
A total of 25 inpatients with a diagnosis of schizophrenia were considered eligible from 11 
wards across GG&C.  Of those, 16 agreed to be approached, one was unable to complete 
the consent form and one individual refused to take part as there was no remuneration.  
From the 14 that consented, Rowan bank, Gartnaval and Leverndale rehab wards each 
provided four participants and two were recruited from Leverndale low secure wards.  One 
individual was unable to complete the study as they became unwell after their first meeting 
with the researcher. This participant did not complete the BDI-II.  Most of the participants 
(9) were able to complete the study in one session, one individual required four separate 
visits from the researcher to complete the study and four participants required two visits to 
complete the study. Participants included 13 males and one female all with a diagnosis of 
schizophrenia.  The mean age of the total sample was 41.71 (12.33) years with a range of 
27 years to 71 years and the mean age of male participants was 39.46 (9.36) years with a 
range of 27 years to 55 years. 
 
 
 
 
 
 
 
 
 
Figure 2.1: Flow diagram of study recruitment. 
 
 
 
 
 
Leverndale	MH	
inpatient	wards	
	
9	participants	
identified	
	
Gartnaval	MH				in	
patient	wards		
	
6	participants	
identified	
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Forensic	wards		
	
3	participants	
identified	
	
Rowanbank	
Medium	Secure		
	
7	participants	
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1	refused	
4	completed	
1	unable	to	
complete	
	
	
2	refused	
4	completed	
1	unable	to	
complete	
	
1	refused	
2	completed	
	
5	refused	
4	completed	
	
	
 Total identified = 25    Total refused = 9                 Unable to sign consent = 1 
               Unable to complete = 1 
               Total completed = 13 
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Table 2.1:  Median and IQR on all study variables 
 
Measure Median IQR 
SNS total 
• Social withdrawal 
• Diminished emotional 
range 
• Avolition 
• Anhedonia 
• Alogia 
12  
1 
3 
 
1 
1.5 
4 
14 
5 
5 
 
4 
4 
2 
BDI-II 10 5 
Social Problem solving 
• NPO 
• PPO 
• AS 
• RPS 
• ICS 
 
4.5 
13.5 
8 
11.5 
5 
 
4 
8 
7 
8 
7 
MEPS 
• Mean steps 
• Effectiveness 
 
6 
8.5 
 
5 
7 
AMT 25 12 
MAS-A 
• Total 
• Self-reflectivity 
• Understanding others 
• Dencentration 
• Mastery 
 
9.5 
3.25 
2 
0 
2.5 
 
7 
1 
1 
1 
3 
 
Table 1 shows all the median scores for all study variables. 
 
 
Relationship between NPO and negative symptoms of schizophrenia  
To examine the main study hypothesis, that we expect there to be a positive correlation 
between negative problem orientation (NPO) and the negative symptoms of schizophrenia 
a Spearman’s rho correlation analysis was conducted to examine the relationship between 
NPO and negative symptoms subscales and the total score of the scale for negative 
symptoms of schizophrenia. 
 
 
Table 2.2: Spearman’s rho correlation of NPO and negative symptoms of 
schizophrenia. 
 
 NPO SW DER AV AN Alogia TSNS 
 NPO - .31 .38 .25 .19 .14 .33 
SIG  .28 .19 .40 .19 .14 .25 
N 14 14 14 14 14 14 14 
NPO: negative problem orientation; SW: Social withdrawal; DER: Diminished emotional range; AV: 
avolition; AN: anhedonia and TNS: total scale for negative symptoms. 
 
Correlation is significant at *P  < .05; ** P < .01 
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Table 1 shows that NPO was not significantly associated with any scores on the SNS, 
which did not support the study hypothesis.   
 
Differences between predominant and prominent negative symptom profiles in 
schizophrenia. 
In order to test our exploratory hypotheses (i) Individuals with predominant symptoms will 
be poorer at social problem-solving than those with prominent negative symptoms and (ii) 
that individuals with predominant negative symptoms will have poorer meta-cognitive 
abilities than those with prominent negative symptoms median scores for predominant and 
prominent symptoms groups across study variables of social problem-solving and meta-
cognition. Table 3 shows that the group with predominant symptoms were found to have 
slightly lower median scores on all of the social problem-solving subscales (both SPSI-R 
and MEPS) apart from AS.  These results show some support for the study hypothesis that 
those with predominant symptoms would score lower on social problem-solving. 
 
The median scores for meta-cognition, were higher for the predominant group on all 
subscales apart from decentration.  These results do not support the study hypothesis that 
those with predominant symptoms would be poorer at meta-cognition. 
 
Table 2.3: Median and IQR scores for the predominant and prominent groups on 
key study variables 
 
Variable 
Predominant 
n = 8 
Median        IQR            
 
Prominent n = 6 
 
Median        IQR            
 
PPO 13.50 9 14.00 8 
NPO 4.50 8 5 10 
RPS 10.50 10 11.50 7 
ICS 4.5 8 5.5 8 
AS 8 6 7.50 9 
MEPS  
Means 
Effectiveness 
 
5.5 
7.50 
 
8 
6 
 
6.5 
9 
 
3 
8 
MAS total 10.00 7 8.75 6 
Self-reflectivity 3.00 1 2.00 1 
Understanding 
others 
2.00 1 2 .63 
Decentration 0 0 .5 1 
Mastery 3.50 4 2.5 4 
PPO: positive problem orientation; NPO: negative problem orientation; RPS: rational problem-solving;                 
ICS: impulsive/careless problem-solving; AS: avoidance style; SW: social withdrawal; DER: diminished  
emotional range.  
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Post hoc analysis 
 
Table 2.4 shows that PPO was significantly negatively correlated with avolition (rs = - .52, 
p < .05) and RPS was significantly negatively correlated with alogia (rs = - .55, p < .05). 
 
Table 2.4: Spearman’s rho correlations, of social problem-solving and negative 
symptoms of schizophrenia. 
 
 1 2 3 4 5 6 7 8 9 10 
1. PPO        -          
2. NPO -.39 -         
3. RPS .70* -.17 -        
4. ICS .34 .19 -.08 -       
5. AS .04 .62* .13 .34 -      
6. SW -.52 .31 -.58 .06 .15 -     
7. DEM .08 .38 -.06 .47 .24 .47 -    
8. Avolition -.52* .28 -.45 -.15 .24 .72* .24 -   
9. Anhedonia -.41 .19 -.40 .60 .33 .55* .28 .78** -  
10. Alogia -.43 .14 -.55* .31 .13 .49 .23 .18 .20 - 
PPO: Positive problem orientation; NPO: Negative problem orientation; RPS: Rational problem-solving; 
ICS: Impulsive/careless problem-solving: AS: Avoidance style; SW: Social withdrawal; DEM: 
Diminished emotional range.  
 
Correlation is significant at *P  < .05; ** P < .01 
 
 
Social problem-solving and meta-cognition 
 
Spearman’s rho correlation analysis was conducted to examine the relationship between 
the four subscales of meta-cognition and the MEPS-R. 
 
 
Table 2.5: Spearman’s rho Correlations with interpersonal problem-solving and 
mastery 
 
 
Means-End Problem-solving Mastery 
Mean-steps rs = .64, p < .05 
Effectiveness rs= .63, p <.05 
 
Table 5 shows that the mastery subscale of the MAS for metacognition was significantly 
positively correlated with mean steps and effectiveness ratings of the MEPS (rs = .64, p 
<.05; rs = .63, p <.05). 
 
Autobiographical memory, social problem-solving and meta-cognition 
AM was not found to be significantly associated with any variables within this study. 
 
 
	 40	
2.6 Discussion 
Main findings 
This study did not find support for the main hypothesis that there would be a positive 
correlation between negative problem orientation (NPO) and the negative symptoms of 
schizophrenia.  We also did not find support for our exploratory hypotheses, that 
individuals with predominant symptoms would be poorer at social problem-solving and 
meta-cognition than those with prominent negative symptoms. Post hoc analysis found that 
the mastery sub-scale of meta-cognition was positively associated with actual problem-
solving ability. 
 
Social problem-solving, meta-cognition and negative symptoms of schizophrenia  
Interestingly, a negative relationship was found between positive problem orientation 
(PPO) and the negative symptom of avolition. This could mean that if problems are seen as 
overwhelming or challenging then they will be avoided and this may generalise to a pattern 
of limited goal pursuit and motivation to confront challenges. 
Although not what we predicted it does provide partial support for how orientation to 
solving a problem is connected to levels of negative symptoms of schizophrenia.  
 
A negative relationship was found between rational problem-solving (RPS) and alogia.   
This means that individuals who are able to explore various options when trying to solve a 
problem are able to interact and communicate with others.  Therefore, if individuals are 
experiencing high levels of alogia then it would be very difficult to be able to explore 
options to solve problems.  Nevertheless, these finding are highly speculative and we must 
be cautious of the character of these observations. 
 
Our study found that those with positive attitudes towards their ability to solve problems 
have reduced levels of avolition, which supports previous research by Grant et al. (2011). 
They found that by focusing on what one can do and be positive in attitude can help to 
improve drive and motivation.  These sub-types of negative symptoms are important to 
them exerting a more pernicious and disabling effect on individual with schizophrenia.   
In addition our findings would support Revheim et al. (2006) who found that negative 
symptoms predict problem-solving skills but we are able to extend this finding.  Revheim 
et al. (2006) examined problem-solving as a whole construct, whereas, we examined 
specific constructs of problem solving.  In particular we examined functional and 
dysfunctional styles and their relationship with specific negative symptoms of 
schizophrenia.  
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The mastery subscale of metacogntion and actual social problem-solving performance 
were found to be positively associated.  This may mean that the ability to use one’s own 
mental state is crucial for actual problem-solving ability.  This is an interesting finding and 
could help us to understand the relationship between meta-cognition and social problem-
solving which will be important to understand these processes for interventions.  
 
Limitations  
A major limitation with this study was the parameters set around eligibility criteria which 
proved challenging for clinicians to identify appropriate participants.  Also, due to the 
nature of negative symptoms and their impact on functioning some participants did 
struggle with the detail and length of the study.  In addition, classifying predominant and 
prominent symptoms was not carried out adequately and therefore this categorization is 
questionable within the recruited participants. It is also likely that participants were under 
reporting their symptoms due to their environment in order to appear well.  Many 
participants reported that they did not agree with their diagnosis and may have been 
motivated to appear well due to the levels of restrictions place on them.  Therefore, it is 
likely that there was a bias of reporting symptoms and it may be that a community sample 
may have been more appropriate for this study.   
 
Another major limitation was that he study was powered for a key hypothesis. It could be 
that the effect size is much smaller in patients experiencing difficulties with negative 
symptoms and a larger sample size was required. Due to the low sample size the secondary 
hypotheses were underpowered and therefore type II error is likely.  Negative symptoms 
were a key variable in this study therefore it may have been prudent to employ a secondary 
measure which could have been completed by staff. This may have allowed for more 
accurate measurement, which may also have helped with the allocation of the sample into 
predominant and prominent symptoms.  
 
Future research 
Due to the difficulties with recruitment we would suggest that future research in this area 
recruit in a community population with a larger sample size. This was an exploratory study 
with major limitations but future studies could focus on the relationship with meta-
cognition and problem-solving performance in order to substantiate any findings.  Future 
research should also consider how negative symptoms profiles are identified, as this is 
crucial to the nature of this research.  If social problem-solving and meta-cognition are 
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associated then it could mean that enhancing social problem-solving skills could help 
individuals to integrate more and improve the quality of their lives. 
 
Conclusion 
Post hoc analysis found that the negative symptoms of avolition and alogia are positively 
associated with the functional problem-solving constructs of RPS and PPO.  We also found 
that the meta-cognition subscale of mastery was positively associated with actual problem-
solving ability. Whilst this study experienced major methodological limitations these 
findings suggest that attitudes and actual problem-solving ability are important factors in 
relation to interventions for negative symptoms.  Due to the exploratory nature of this 
study we have highlighted challenges in conducting research in this population and as such 
we suggests that future research may prove more fruitful in a community population. 
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Web references
As a minimum, the full URL should be given and the date when the reference was
last accessed. Any further information, if known (DOI, author names, dates,
reference to a source publication, etc.), should also be given. Web references can
be listed separately (e.g., after the reference list) under a diﬀerent heading if
desired, or can be included in the reference list.
Reference management software
This journal has standard templates available in key reference management
packages EndNote (http://www.endnote.com/support/enstyles.asp
(http://www.endnote.com/support/enstyles.asp) ) and Reference Manager
(http://refman.com/support/rmstyles.asp
(http://refman.com/support/rmstyles.asp) ). Using plug-ins to wordprocessing
packages, authors only need to select the appropriate journal template when
preparing their article and the list of references and citations to these will be
formatted according to the journal style.
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Responsibility for the accuracy of bibliographic citations lies entirely with the
authors.
Text: All citations in the text should refer to:
1. Single author: the author's name (without initials, unless there is ambiguity) and
the year of publication;
2. Two authors: both authors' names and the year of publication;
3. Three or more authors: first author's name followed by 'et al.' and the year of
publication.
Citations may be made directly (or parenthetically). Groups of references should
be listed first alphabetically, then chronologically.
Examples: "as demonstrated (Allan, 1996a, 1996b, 1999; Allan and Jones, 1995).
Kramer et al. (2000) have recently shown ...."
List: References should be arranged first alphabetically and then further sorted
chronologically if necessary. More than one reference from the same author(s) in
the same year must be identified by the letters "a", "b", "c", etc., placed after the
year of publication.
Examples:
Reference to a journal publication:
Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., 2000. The art of writing a scientific
article. J. Sci. Commun. 163 (2) 51-59.
Reference to a book:
Strunk Jr., W., White, E.B., 1979. The Elements of Style, third ed. Macmillan, New
York.
Reference to a chapter in an edited book:
Mettam, G.R., Adams, L.B., 1999. How to prepare an electronic version of your
article, in: Jones, B.S., Smith , R.Z. (Eds.), Introduction to the Electronic Age. E-
Publishing Inc., New York, pp. 281-304.
Journal names should be abbreviated according to the List of serial title word
abbreviations: http://www.issn.org/services/online-services/access-to-the-ltwa/
(http://www.issn.org/services/online-services/access-to-the-ltwa/)
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Preparation of electronic illustrations and services
General points
•Always supply high-quality printouts of your artwork, in case conversion of the
electronic artwork is problematic.
•Make sure you use uniform lettering and sizing of your original artwork.
•Save text in illustrations as "graphics" or enclose the font.
•Only use the following fonts in your illustrations: Arial, Courier, Helvetica,
Times, Symbol.
•Number the illustrations according to their sequence in the text.
•Use a logical naming convention for your artwork files, and supply a separate
listing of the files and the software used.
•Upload all illustrations as separate files.
•Provide captions to illustrations separately.
•Produce images near to the desired size of the printed version. This journal
oﬀers electronic submission services and graphic files can be uploaded via the
online submission system.
A detailed guide on electronic artwork is available on our
website:http://authors.elsevier.com/artwork/schres
(http://authors.elsevier.com/artwork/schres)
You are urged to visit this site; some excerpts from the detailed information are
given here.
Formats
Regardless of the application used, when your electronic artwork is finalised,
please "save as" or convert the images to one of the following formats (Note the
resolution requirements for line drawings, halftones, and line/halftone
combinations given below.):•EPS: Vector drawings. Embed the font or save the
text as "graphics".
•TIFF: Colour or greyscale photographs (halftones): always use a minimum of 300
dpi.
•TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
•TIFF: Combinations bitmapped line/half-tone (colour or greyscale): a minimum
of 500 dpi is required.
•DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft
Oﬃce applications please supply "as is".
Please do not:
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•Supply embedded graphics in your wordprocessor (spreadsheet, presentation)
document;
•Supply files that are optimised for screen use (like GIF, BMP, PICT, WPG); the
resolution is too low;
•Supply files that are too low in resolution;
•Submit graphics that are disproportionately large for the content.
Captions
Ensure that each illustration has a caption. Supply captions on a separate sheet,
not attached to the figure. A caption should comprise a brief title (not on the
figure itself ) and a description of the illustration. Keep text in the illustrations
themselves to a minimum but explain all symbols and abbreviations used.
Colourful e-Products
Figures that appear in black & white in print appear in colour, online, in
ScienceDirect at http://www.sciencedirect.com  (http://www.sciencedirect.com) .
There is no extra charge for authors who participate.
For colour reproduction in print, you will receive information regarding the costs
from Elsevier after receipt of your accepted article. Please indicate your
preference for colour in print or on the Web only. Because of technical
complications, which can arise by converting colour figures to "grey scale" (for the
printed version should you not opt for colour in print) please submit in addition
usable black and white versions of all the colour illustrations. For further
information on the preparation of electronic artwork, please see
http://authors.elsevier.com/artwork/schres
(http://authors.elsevier.com/artwork/schres)
AudioSlides
The journal encourages authors to create an AudioSlides presentation with their
published article. AudioSlides are brief, webinar-style presentations that are
shown next to the online article on ScienceDirect. This gives authors the
opportunity to summarize their research in their own words and to help readers
understand what the paper is about. More information and examples are
available at http://www.elsevier.com/audioslides
(http://www.elsevier.com/audioslides). Authors of this journal will automatically
receive an invitation e-mail to create an AudioSlides presentation after
acceptance of their paper.
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Abstract 
 
 
Background 
Schizophrenia can be marked by debilitating negative symptoms that are often 
treatment resistant.  Negative symptoms may be linked to difficulties with meta-
cognition and social problem-solving.  Autobiographical memory retrieval deficits 
have previously been linked to meta-cognition and social problem-solving in 
individuals with schizophrenia. These cognitive factors go some way to explain the 
profound social difficulties that an individual can experience as a result of the 
negative symptoms of schizophrenia.   
 
Aims 
This study aims to examine individuals with psychosis to understand how meta-
cognitive, autobiographical and social problem-solving deficits vary in relation to 
negative symptom profile. 
 
Methods 
Participants who have a diagnosis of psychosis will be recruited from inpatient 
wards in the forensic directorate of GG&C and be grouped according to the 
presence of predominant versus prominent negative symptoms. Participants will 
meet with the researcher face to face and be asked to respond to which will probe 
meta-cognitive capacity, scenarios concerning social problem-solving performance 
and autobiographical memory.  The procedure is expected to take about 90 
minutes. 
  
Applications 
This study will validate revised measures in social problem-solving and help to 
improve understanding of the relationship between meta-cognition and social 
problem-solving in those who experience negative symptoms. This will inform 
psychological treatment models and strategies. 
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Introduction 
 
Schizophrenia affects about 1% of the population and appears to be caused by 
genetic and environmental factors.  DSM-5 (American Psychiatric Association, 
2010) describes symptoms of schizophrenia to include positive symptoms and 
negative symptoms.  Positive symptoms include delusions and hallucinations while 
negative symptoms can include poverty of speech and action, difficulties 
sustaining intersubjectivity, failure to sustain social relations, problems expressing 
one’s own emotions and poor understanding of the emotions, intentions and 
communication of others (American Psychiatric Association, 2010).  Positive 
symptoms can respond more readily to antipsychotic medication than negative 
symptoms which can be persistent and are associated with poor functioning and 
quality of life (Elis, Caonigro & Kring, 2013) and are resistant to pharmacological 
medication (Barns & Paton, 2011). Therefore greater understanding of negative 
symptoms and the mechanisms involved in these deficits is important. 
 
Negative symptom profiles in people diagnosed with schizophrenia can be divided 
into those that are predominant (only negative symptoms present) versus 
prominent negative symptom profiles (marked by the presence of both positive 
and negative symptoms (Carpenter, Heinrichs, Wagman, 1998). McLeod, Gumley 
& Schwannauer, 2014) report that different sub-types of negative symptoms have 
different prognostic implications and therefore, treatments work differently for 
different subtypes of negative symptoms. By their nature negative symptoms are 
associated with impairments in social functioning (Hooley, 2010) and deficits in 
social problem-solving. 
 
In one of a few RCTs for negative symptoms, Grant, Huh, Perivoliotis, Stolar and 
Beck (2011) found cognitive therapy to be effective for individuals with a diagnosis 
of schizophrenia who were cognitively impaired and experienced low functioning.  
They adapted the therapy to accommodate difficulties related to low functioning 
and aimed it at factors which impede goal attainment, one such factor being 
defeatist beliefs (If you cannot do something well, there is little point doing it at all).  
The treatment group experienced improvement in global functioning and a 
reduction in avolition-apathy, indicating that cognitive therapy can produce 
meaningful improvements. This result is consistent with demonstrated 
associations between negative symptoms and defeatist beliefs (Grant & Beck, 
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2009).  The construct of defeatist beliefs is similar to negative problem orientation 
(NPO) which can adversely affect the initial cognitive stage of social problem-
solving (D’Zurilla & Goldfried, 1971).  However, it is unknown whether there is a 
relationship between NPO and the negative symptoms of schizophrenia.  This 
warrants attention given the intersection between negative symptoms, defeatist 
cognitions, poor social functioning in people diagnosed with schizophrenia. 
 
D’Zurilla & Goldfried (1971) consider social problem-solving to be a cognitive 
behavioural process and a vital skill needed to prosper in society as such it is an 
important factor in behavioural adjustment. D’Zurilla and Goldfried’s (1971) model 
of social problem-solving was not formulated for severe psychiatric conditions, 
however it would seem that that the characterisation of social problem-solving as a 
key contributor to psychological wellbeing is also relevant to individuals with a 
diagnosis of schizophrenia (Morris, Bellack & Tenhula, 2004). Individuals with 
schizophrenia have been found to have deficits in social problem-solving 
(Hatahita-Wong, Smith, Silverstein, Hull and Wilson, 2002). Importantly, Revheim, 
Schechter, Kim, Silipo, et al. (2006) found that social problem-solving is negatively 
associated with negative symptoms of psychosis.  These findings help to explain 
why individuals who experience negative symptoms of schizophrenia are more 
likely to be socially isolated, never marry and have poor communication skills.  
Nevertheless, social problem-solving is a cognitive behavioural function that is 
complex and dysfunctional social problem-solving has found to be affected by 
other factors which include mood (Goddard, Dritschel, & Burton, 1996) and 
autobiographical memory (Williams, 1998). 
 
Individuals with schizophrenia have been found to have deficits in both 
autobiographical memory (Wood, Brewin & McLeod, 2006) and social problem-
solving (Morris et al, 2004). Studies have shown that social problem-solving is 
closely linked to autobiographical memory ability (Goddard, Dritschel and Burton, 
1996). Further to this, neuroscience research using brain-imaging studies, 
suggests that there is a link in brain areas that support both autobiographical 
memory and meta-cognitive functions (Dimaggio, Salvatore, Poplolo & Lysaker, 
2012).  This link in brain structures therefore means that these two cognitive 
functions support each other and that disruption in one could lead to disruption in 
the other. It would seem reasonable to suggest that social problem-solving is also 
connected with these same brain structures.  
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Meta-cognitive capacity deficits are posited to be more pronounced in individuals 
with schizophrenia and they have been found to be associated with negative 
symptoms (Dimaggio, Salvatore, Popolo & Lysaker, 2012).  Meta-cognitive 
capacities include the ability to shift back and forward from ones own perspective 
to that of others (Lysaker & Dimaggio, 2014).  This is important because being 
able to form complex ideas about oneself and others enables one to respond to 
psychological challenges. In other words this capacity allows us to form meanings, 
which are crucial in sustaining connections with family and friends as well as the 
community.  This would also suggest that meta-cognitive capacities are key to 
effective social problem-solving. 
 
Lysaker and Dimaggio (2014) developed an interview that has the capacity to 
measure an individual’s ability to form complex representations of their self and 
others (Indiana Psychiatric Illness Interview; IPII).  These authors argue that this 
new research paradigm is a method by which to measure the core disturbances in 
the consciousness of individuals with schizophrenia.  Therefore, the utility in 
measuring one’s meta-cognitive capacity could help elucidate the impact of meta-
cognition on social problem-solving ability. 
 
Salvotore and Dimaggio (2007) argue that the negative symptoms of 
schizophrenia can be understood under the context of simulation theory which 
proposes that our awareness of others minds is based on an innate ability to use 
our own experiences as a model.  This ability is described as a simulation process, 
which is implicit and non-conscious actions and key to understanding the minds of 
others and the meaning of their communication. This theory can help to explain 
the difficulties in meta-cognitive capacities and deficits in social problem-solving.   
 
Both meta-cognitive and social problem-solving rely on previous experience to 
function, this could therefore mean that they both rely on intact autobiographical 
memory to function effectively.  Nevertheless, there is a dearth of research that 
explores this triad of cognitive factors and how they differ between sub-types of 
negative symptoms. 
 
Understanding the interface between problem-solving, autobiographical memory, 
and metacognition functioning also has particular relevance in forensic contexts.  
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Poor social problem-solving may account for criminal behaviour in mentally 
disordered offenders (McMurran et al, 2001) and it could be argued that some 
offences may be a maladaptive way in which to solve an interpersonal problem.  
Forensic patients are a heterogeneous group with a range of mental disorders 
which can include brain damage; personality disorder; psychopathy; learning 
disability; depression; bipolar and schizophrenia (Hodgins and Muller-Isberner, 
2001).  With this in mind it seems fit to conduct this study with this population. 
 
In summary, individuals with schizophrenia experience negative symptoms that 
can be linked to basic brain processes involved in intersubjectivity and mental 
state processing (Salvotore and Dimaggio, 2007). This may result in an inability to 
understand the minds of others and the meaning of their communication and this 
in turn may cause social isolation and problematic relationships. Individuals with 
negative symptoms are poorer at social problem-solving  (Morris, et al 2004; 
Revheim et al, 2004) and it is well established in the literature that deficits in AM 
will predict poor social problem-solving (Goddard et al, 1996).  Meta-cognitive 
abilities and AM also appear to be closely linked (Dimaggio et al, 2012) however, 
what is not clear is the relationship between these three key cognitive functions 
and their differences, if any in the subtypes of negative symptoms.   
 
Psychological interventions may be promising treatments for decreasing the 
negative symptoms of schizophrenia.  This is important because negative 
symptoms substantially affect quality of life and defeatist beliefs are posited to be 
key mediator of cognitive impairment, negative symptoms and functioning (Grant & 
Beck, 2009).  Although untested to date, it can be argued that defeatist beliefs 
impair social functioning in a similar way to negative problem orientation (NPO).  
Therefore this study examines the link between social problem-solving, NPO and 
the negative symptoms of schizophrenia. This will help identify effective targets for 
psychological intervention programmes.  
 
Aims and research questions 
This study will examine individuals with psychosis to understand how meta-
cognitive, autobiographical memory and social problem-solving deficits interact 
with negative symptom presentation profiles.  
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Specific research questions include: (i) What is the nature of the relationship 
between social problem solving and the negative symptoms of schizophrenia? (ii) 
Do individuals with predominant negative symptoms exhibit more deficits in meta-
cognition, autobiographical memories and social problem-solving than those with 
prominent symptoms of psychosis?  (iii) Do defeatist beliefs and negative problem 
orientation (NPO) relate to negative symptoms in the same way that NPO and 
depression scores relate? 
 
Study hypotheses 
(i) We expect there to be a positive correlation between negative problem 
orientation and the negative symptoms of schizophrenia.  
 (ii). We predict that individuals with predominant negative symptoms will have 
poorer meta-cognitive abilities and social problem-solving than those with 
prominent negative symptoms. 
 (iii) Individuals with predominant symptoms will be poorer at observed 
interpersonal social problem-solving than those with prominent negative 
symptoms. 
 
 
Plan of Investigation 
 
Design 
 
This will be a between subjects, cross-sectional study of inpatients from 
Rowanbank medium secure unit and Leverndale low secure unit. 
 
Participants 
 
Inpatient participants will be recruited who meet the DSM-5 criteria for a diagnosis 
of psychosis from the forensic directorate of Greater Glasgow and Clyde NHS.  
Participants will be over 18 years and be either male or female within GG&C 
patients will be pooled from Rowan Bank medium secure unit, which has a 
capacity for 74 patients and Leverndale low secure unit which has capacity for 50 
patients.  Participants will be split into two groups, those with predominant 
symptoms and those with prominent symptoms, these groups will be allocated with 
the assistance of clinical staff.  Exclusion criteria will include traumatic brain injury, 
learning disability, those not able to provide informed consent and those whose 
first language is not English. RMOs, psychologists and nursing staff will be 
approached to assist with the recruitment of inpatients. 
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Measures 
 
The following measures will be employed; Self-evaluation of Negative symptoms 
(SNS; Dollfus & Mach, 2014); The Indiana Psychiatric illness Interview (IPI; 
Lysaker, Clements, Plascak-Hallberg, Knipscheer & Wright, 2002); The Means-
end Problem-solving Task Revised (MEPS-R; Miller, O’Carroll & O’Connor, 
Unpublished Thesis); The Autobiographical Memory Test (AMT; Williams and 
Broadbent, 1986); The Beck Depression Inventory (BDI-II; Beck, Steer & Brown, 
1996) and the Social Problem-Solving Inventory (SPSI-R; D’Zurilla, Nezu & 
Maydeu-Olivares, 2002).   
 
 
Research Procedures 
 
Participants will be identified through discussion with treating clinicians (e.g. 
nurses, psychiatrist, psychologist) and only people with capacity to consent to 
participation will be approached.  Once eligible participants have been identified 
they will be invited to meet with the researcher.  The study will be explained again 
using the information sheet, if they agree to take part in the study they will be 
invited to provide informed consent.  
 
If participants become unwell or distressed during the study then the researcher 
will contact a member of the clinical team, end the study and allow the participant 
to be treated appropriately.  If it is appropriate then the participant will be 
approached and asked at a later date if they would wish to continue with the study.   
 
The researcher will check frequently for the duration of the study that the 
participant is ok and happy to continue to the next task, and also offer frequent 
breaks. 
  
The initial information and consent phase is expected to take about 10 minutes. 
 
Participants will then be presented with a questionnaire packet, this will include the 
measures of social problem-solving (SPSI-R), mood (BDI) and negative symptoms 
checklist (SNS).  This will take each participant about 15 minutes to complete.  
 
Social problem-solving task (MEPS-R; Miller, O’Carroll & O’Connor, Unpublished 
Thesis). 
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Participants will then be informed that four scenarios will be read aloud to them; in 
addition they will be shown a card with each scenario written on it.  Participants 
will be advised that each scenario will include a problem to be solved and that they 
will also be provided with the ending to the problem.   Participants are required to 
describe the best way to solve the problem, in other words they must connect 
together the beginning and the end of each of the scenarios, providing the ‘ideal 
strategy’ to solving the problem (Marx, et al., 1992).  As participants describe how 
they would solve each problem scenario the researcher will record this information 
by writing out their responses and in addition will be audio recorded.  The four 
scenarios will be randomised using a web-based randomizer programme to 
allocate the order in which the scenarios will be presented to each participant. This 
is expected to take about 15 minutes to complete. 
 
Autobiographical memory task (Williams and Broadbent, 1986). 
Participants will then be asked to generate a specific memory to five positively 
cued words (happy, safe, interested, successful and surprised) and five negative 
words (sorry, angry, clumsy, hurt and lonely).  Each participant will be given three 
practice words and this is expected to take about 15 minutes to complete.   
 
Meta-cognition (Indiana Psychiatric Illness Interview; Lysaker, 2002). 
A semi-structured interview will be employed to assess narratives of illness. At this 
stage it is anticipated that some rapport will be formed, as the interview is 
conversational in nature. The interviewer does not ask questions about specific 
symptoms but may ask for clarification and further information.  This is expected to 
take about 20 minutes. 
 
The participant will then be informed that the study is completed, and invited to ask 
any questions. This is expected to take 5 minutes. 
 
The whole procedure is expected to take approximately 80 minutes; due to the 
length of the study participants will be offered a break of ten minutes, the total 
length of time for the study will be 1 hour 30 minutes. 
 
Data analysis 
SPSS 22 will be used to run descriptive analyses, correlations and t-tests.  Five 
participants will be randomly selected to be scored by a second-rater. 
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Data cleaning will be carried out to check for missing values and outliers..  
Violations of assumptions of normality and equal variance will be checked by using 
normality tests and graphs.  If there are any violations of assumptions 
consideration will be given to transforming the data. Cases will large volumes of 
missing data will be excluded but, where possible, missing responses will be 
imputed with mean values of the data set. 
Correlational analysis will be run to test for the main effect of the relationship 
between negative symptoms of psychosis and negative problem orientation. 
 
Data Management Plans 
All data will be anonymised by providing each participant with a unique 
identification number, which will conceal their identity on all paper and electronic 
files.  All qualitative data will have identifiable information removed. This data will 
be saved to an encrypted memory stick and only be used on NHS computers.  All 
data will be backed up on a secure network.  Encrypted audio recording device 
information will be transcribed using a NHS computer and saved on an encrypted 
memory stick. All NHSGG&C data protection and information transfer policies will 
be adhered to across the conduct of the study.  The only person who will have 
access to the data is the principle investigator and if required for audit purposes 
the study sponsor NHS GG&C. 
 
Justification of sample size 
It still needs to be determined how much there is a link between the problems with 
negative symptoms of schizophrenia and the negative problem orientation of 
social problem-solving.  There is no study to use for effect sizes but we have 
investigated studies in social problem-solving and then averaged the effect sizes 
to enable us to calculate power for this study allowing us to detect an effect.  The 
sample size was determined by reviewing related studies, D’Zurilla, Nezu, 
Maydeu-Olivares (2002) report in the Technical Manual that NPO is consistently 
the best predictor across distress measures, in particular the Beck Depression 
Inventory (BDI) and reported correlations of .49 in a college sample; .66 in a 
middle age sample and .66 with psychiatric inpatients. Miller, O’Carroll & O’ 
Connor, unpublished thesis) detected a correlation of .66 correlation between NPO 
and the BDI. Therefore the power analysis is focused on negative symptoms of 
psychosis and the relationship between defeatist beliefs and problem orientation. 
A power analysis was conducted using G* power 3 computer software (Faul et al; 
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2007) with a medium effect size of .60, alpha set at .05 and a power calculation of 
.8 this yielded a sample size of 13 for the correlational analysis.  The medium 
effect size was calculated by averaging the correlations of the studies previously 
reported. In summary, the aim is to detect an effect between NPO and negative 
symptoms of schizophrenia by recruiting a total sample size of 13. If participants 
withdraw then clinical teams will be informed to identify additional particpants. 
 
Settings and Equipment 
It is anticipated that this research will take place in the inpatient wards at Rowan 
Bank and Leverndale Hospital.  Staff will be approached in advance to establish a 
room within the ward on the days the study is running.  Equipment will include 
prepared materials and also a study pack for recording all data collection with 
each participant. 
 
Health and Safety Issues 
Prior to each visit ward managers will be contacted to ensure that the conditions 
on the ward are suitable for the researcher to visit and that identified patients are 
able to take part. 
 
Researcher safety issues 
The researcher has completed Breakaway training.  On each day of the study they 
will receive a briefing from staff if there are any safety issues surrounding any 
patients; be provided with a personal alarm; ensure that staff are aware of my 
location and have checked the layout of the room prior to the study commencing. 
 
Participant safety issue 
Participants will be informed that they can leave the study at any time and they will 
be offered a break.  If the researcher feels that a participant appears to be agitated 
or upset in any way due to the study then they will discontinue to ensure the well-
being of the participant.  Ward staff will also be informed to ensure that the patient 
remains safe and well and is not duly upset.   
 
 
Dissemination of results 
Results of this research will be reported via a doctoral thesis, in addition 
conference presentations and scientific journals.  Participants will be provided with 
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contact details if they wish to find out the results of the study in general, they will 
not be provided with individual feedback after the study. 
 
 
Ethical Issues 
Ethical approval will be sought from the NHS ethics board and the directorate of 
forensic clinical psychology ethics committee. 
 
Participants will be identified as having capacity by the clinical team in order to be 
considered for the study.  Participants will be informed that they can withdraw from 
the study at any time or that they do not need to answer any questions they do not 
wish to.  All participant data will be linked to a research identification number to 
ensure confidentiality, which will be held separately from the research data. 
 
Financial Issues 
There are no known financial issues. 
 
Equipment and stationary costs etc. 
It is anticipated that about 300 photocopies (at 5p each) will be made which will be 
a cost of £15.00.  A ream of paper (500 sheets) is cost at £2.18, making the total 
cost of £17.18. 
 
Timetable 
June 2016 submit ethics application 
January 2016 to March 2017 data collection 
March 2017 data analysis 
April/May write up  
June 2017 first draft submission 
End July 2017 thesis submission 
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Plain English summary 
 
Social problem-solving involves actions and thoughts about how to deal with 
everyday problems of ourselves and others.  In forensic patients we know that this 
skill is very poor and can therefore have an impact on the choices that they make 
and this can result in becoming involved with forensic services. 
 
A large proportion of forensic patients with mental health problems have a 
diagnosis of psychosis.  It is the negative symptoms of psychosis that can have a 
bigger impact on day to life, for example they may have less social contact and be 
involved in less pleasurable activities.  Negative symptoms are not as easy to treat 
as positive symptoms, which can be reduced with medication.  Therefore it is 
important that research focus more closely on negative symptoms to help us find 
different ways to treat these symptoms. 
 
Poor social problem-solving is common in individuals who experience negative 
symptoms of psychosis.  We are now beginning to understand that part of their 
difficulties involves thinking about thinking (meta-cognition).  So, if you struggle to 
be able to think about how a person might respond or act to something you might 
say or do; then it seems more understandable why they may say or do things that 
are deemed socially unacceptable. We also know that psychological therapies do 
help with the negative symptoms of psychosis but for them to be more effective we 
need to understand more about the sub-groups of negative symptoms. Therefore, 
this research is important, the more we know about all these factors that have a 
negative impact on the quality of someone’s life the more we can adapt 
psychological therapies to try and improve their quality of life. 
 
In this study, we are trying to tease apart the negative symptoms of psychosis, 
social problem-solving and meta-cognition.  We will recruit inpatients from Rowan 
Bank and Leverndale hospital and they will be split into two groups, those with 
only negative symptoms and those with both negative and positive symptoms.  We 
will meet with the participants individually, and then give them some 
questionnaires to answer on their own asking about their mood, symptoms of 
psychosis and how they solve problems. We will then proceed to tasks that will 
involve the researcher asking questions about different scenarios and recording 
their answers.  This will take about 1 hour 30 minutes in total so we will ensure 
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that all participants are provided with a break.  We will also make sure that they 
know they can leave the study at any time.  Staff will be aware of the day when the 
researcher will be in the wards and briefings will be provided before by staff and 
after from the researcher to ensure the wellbeing of the participants. 
 
In summary, the aim of this study is to understand more about the differences in 
social problem-solving between those with negative symptoms and those who 
experience negative and positive symptoms.  We think that we will find differences 
in meta-cognition and social problem-solving between the two groups. 
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Appendix 3 
 
WEST OF SCOTLAND/ UNIVERSITY OF GLASGOW 
DOCTORATE IN CLINICAL PSYCHOLOGY 
 
HEALTH AND SAFETY FOR RESEARCHERS 
 
 
1. Title of Project 
How social problem-solving, meta-cognition and 
autobiographical memory differ in sub-types of 
negative symptoms in psychosis.  
 
2. Trainee  
3. University Supervisor  
4. Other Supervisor(s)  
5. Local Lead Clinician  
6. Participants:  (age,  group or 
sub-group, pre- or post-
treatment, etc) 
Inpatients with a diagnosis of schizophrenia 
7. Procedures to be applied  
(eg, questionnaire, interview, etc) 
Paper questionnaires completed by participant.  
Second part involves scenarios to respond to and then 
a semi-structured interview. 
i) Setting (where will 
procedures be 
carried 
out?)Details of all 
settings 
 
In inpatient settings in a medium secure unit (Rowan 
Bank) and a low secure unit (Leverndale).  Rooms will 
be made available and visited before the study begins.  
Participants will be familiar with them.  Researcher will 
be provided with a personal alarm. 
 ii) Are home visits involved  No 
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WEST OF SCOTLAND/ UNIVERSITY OF GLASGOW 
DOCTORATE IN CLINICAL PSYCHOLOGY 
 
HEALTH AND SAFETY FOR RESEARCHERS 
 
 
9. Potential Risk Factors Considered (for 
researcher and participant safety): 
i) Participants 
ii) Procedures 
iii) Settings 
       
 
 
 
i) Inpatients at Rowan Bank and Leverndale with a 
diagnosis of psychosis. 
 
ii) Procedure is long and may induce distress.  The 
procedures are similar to methods employed by 
clinical psychology 
 
iii) Room in clinical ward which participants will be 
familiar with. 
10. . 10. Actions to minimise risk (refer 
to 9)  
i) Participants 
ii) Procedures 
iii) Settings 
 
 
 
 
 
 
i) Participants will be vetted by clinical staff to reduce 
the risk of unpredictable behaviour. On each day of 
the study I will check with staff the status of each 
participant. 
ii) Participants will be provided with a break and 
informed they can leave the study at any time or 
withdraw.  In addition if the researcher notices that the 
participant appears distressed they will end the study.  
Staff will be debriefed on all participants. 
iii) Room will be visited in advance, staff on day will be 
aware and informed as each participant begins and 
ends study.  Personal alarm will be provided for the 
researcher and has completed breakaway training. 
 
 
 
 
 
Trainee signature:  ...................................................... Date:  ...................................  
 
University supervisor signature: ..........................................  Date: ..........................   
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Appendix 6 
 
 
	
	
	
	
	
	
	
 
South East Scotland REC 01 
Waverley Gate 
2 - 4 Waterloo Place 
Edinburgh 
EH1 3EG 
 
Telephone: 0131 465 5473 
 
 
 
 
03 April 2017 
 
Dr Hamish McLeod 
Institute of health and wellbeing 
University of Glasgow 
1st Floor Admin Building 
Gartnaval Royal Hospital 
1055 Great Western Road 
G12 0XH 
 
 
Dear Dr McLeod  
 
Study title: An examination of meta-cognition and social 
problem-solving in individuals who experience 
psychosis. 
REC reference: 17/SS/0037 
IRAS project ID: 213773 
 
Thank you for your letter of 21 March 2017, responding to the Committee’s request for further 
information on the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Vice-Chair.  
 
We plan to publish your research summary wording for the above study on the HRA website, 
together with your contact details. Publication will be no earlier than three months from the date 
of this opinion letter.  Should you wish to provide a substitute contact point, require further 
information, or wish to make a request to postpone publication, please contact 
hra.studyregistration@nhs.net outlining the reasons for your request. 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above 
research on the basis described in the application form, protocol and supporting documentation 
as revised, subject to the conditions specified below. 
 
Conditions of the favourable opinion 
 
The REC favourable opinion is subject to the following conditions being met prior to the start of 
the study. 
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Participant	information	sheet		
(Version	4	–	20/03/2017)	
	
	
Title	of	Project:	Meta-cognition,	social	problem-solving	and	psychosis.	
	
	
	
Principal	Investigator:		
Jaclyn	MacLeod	
Trainee	Clinical	Psychologist		
Mental	Health	and	Wellbeing		
1st	Floor	Admin	Building		
Gartnavel	Royal	Hospital		
G12	0XN		
Tel:	0141	211	3922		
Academic	Supervisor:		
Dr.	Hamish	McLeod		
Programme	Director/Senior	Lecturer		
Doctorate	in	Clinical	Psychology		
Mental	Health	and	Wellbeing		
1st	Floor	Admin	Building		
Gartnavel	Royal	Hospital		
G12	0XN		
Tel:	0141	211	3922		
Field	Supervisor	(NHS	GG&C)		
Dr	Emma	Drysdale		
Consultant	Forensic	Clinical	Psychologist		
Douglas	Inch	Centre	
2	Woodside	Terrace	
Glasgow	G3	7UY	
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Invitation	to	Participate	in	a	Research	Project	
	
We	would	like	to	invite	you	to	take	part	in	a	research	study.	Before	you	
decide,	you	need	to	understand	why	the	research	is	being	done	and	what	it	
would	involve	for	you.	Please	take	time	to	read	the	following	information	
carefully.	Talk	to	others	about	the	study	if	you	wish.		Ask	us	if	there	is	
anything	that	is	not	clear	or	if	you	would	like	more	information.	Take	time	to	
decide	whether	or	not	you	wish	to	take	part.	
	
Why	do	this	study?	
This	study	is	being	carried	out	by	the	University	of	Glasgow	and	NHS	GG&C.		
The	aim	of	this	study	is	to	better	understand	factors	associated	with	how	you	
think	about	things	and	the	difficulties	you	experience	as	a	result	of	your	
mental	illness.		The	topics	covered	include	social	problem-solving,	memory,	
your	attitudes,	and	your	mood.	
	
Who	is	being	asked	to	take	part?	
We	are	asking	people	who	are	inpatients	in	Forensic	or	general	mental	health	
services	in	Greater	Glasgow	and	Clyde	NHS.		All	individuals	invited	to	take	part	
will	experience	difficulties	with	schizophrenia.	
	
Why	have	I	been	asked	to	take	part?	
A	member	of	the	clinical	team	responsible	for	your	care	(e.g.	Psychiatrist,	
Clinical	Psychologist	or	Nurse)	has	suggested	that	you	might	be	interested	in	
taking	part.	
	
What	does	participation	involve?	
• If	you	consent,	you	will	then	be	asked	to	sign	a	consent	form	to	
participate	when	you	meet	with	the	researcher	in	your	ward.		If	you	
can	direct	any	questions	you	have	to	the	researcher	(Jaclyn)	at	any	
time.		
	
• You	will	be	given	3	written	questionnaires	to	complete	on	your	own,	
these	involve	responding	by	ticking	a	box	that	reflects	the	answer	you	
think	best	applies	to	you.	
	
	
• The	researcher	will	then	read	out	3	lists	of	5	words	and	you	will	be	
asked	to	generate	a	specific	memory.	
	
• The	next	task	involves	responding	to	four	scenarios,	these	ask	how	you	
would	go	about	solving	an	everyday	problem.	
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• You	will	then	be	offered	a	break.		On	return	you	will	be	asked	if	you	are	
happy	to	continue	with	the	study.	
	
• The	final	task	involves	responding	to	some	questions	about	your	life	
and	how	you	feel	about	your	illness.	
	
How	long	will	this	take?	
The	study	may	take	about	1	hour	and	30	minutes	to	complete	but	it	may	take	
you	less	time	than	this.	You	will	be	offered	breaks	as	you	need	them	during	
the	study.		If	you	do	not	wish	to	continue	please	let	the	researcher	Jaclyn	
MacLeod	know.	
	
Who	is	this	research	for?	
This	research	is	being	conducted	by	the	University	of	Glasgow	and	NHS	
GG&C.		This	project	is	part	of	a	Doctorate	in	Clinical	Psychology	course	funded	
by	NHS	Education	for	Scotland.		The	study	has	been	reviewed	by	the	
University	of	Glasgow	and	the	Forensic	Directorate	Ethics	committee	to	
ensure	that	it	meets	the	required	standards.	The	study	was	also	reviewed	by	
the	South	East	Scotland	Research	Ethics	Committee	and	given	a	favourable	
ethical	opinion.	
	
What	happens	to	the	consent	form?	
To	ensure	that	your	information	is	kept	confidential	and	anonymous	(not	able	
to	identify	you),	the	consent	form	will	be	kept	separately	from	all	study	
information	(which	includes	the	transcribed	interview	and	research	forms)	in	
a	locked	filing	cabinet.	This	will	be	within	the	University	of	Glasgow	premises	
in	the	department	of	Mental	Health	and	Wellbeing.	
A	copy	of	your	consent	form	will	also	be	kept	in	your	case	notes.	
	
What	happens	to	the	information	collected?		
Your	responses	will	be	kept	confidential	to	the	researchers	and	will	not	be	
added	to	any	of	your	clinical	records.		The	only	exception	to	this	rule	would	
be	if	you	told	us	something	that	put	you	or	another	person	at	risk.		If	we	
needed	to	break	confidentiality	we	would	make	efforts	to	discuss	this	with	
you	beforehand.		We	will	also	store	all	your	information	in	an	anonymised	
form	by	using	research	codes	instead	of	your	name	in	our	study	database.		All	
records	will	be	stored	securely	and	will	only	be	accessible	by	the	research	
team	or	the	study	sponsor.		
At	the	end	of	the	study,	all	anonymised	research	data	will	be	stored	in	a	
confidential	manner	for	10	years,	and	then	will	be	destroyed.	
	
Is	participation	compulsory?	
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Your	participation	in	this	study	is	completely	voluntary,	and	you	may	
withdraw	at	any	time	without	affecting	your	care	in	any	way.	
If	you	decide	to	withdraw	during	the	study	you	will	be	asked	what	you	would	
like	us	to	do	with	the	information	that	we	have	already	collected.		You	will	
have	two	options.		1.	We	can	still	use	the	information	that	has	been	collected	
or	2.	You	would	like	us	to	destroy	the	information	and	it	cannot	be	used	for	
research	purposes.	
	
What	are	the	benefits	of	taking	part?	
In	general,	research	improves	our	knowledge	of	what	people’s	difficulties	are	
and	what	we	can	do	to	help	people	overcome	these	and	improve	people’s	
lives.	Your	participation	will	help	increase	our	knowledge	of	areas	and	
potentially	improve	treatment	for	others	in	the	future.		
	
What	are	the	risks	of	the	research?	
As	with	all	research	that	asks	about	people’s	health	and	wellbeing,	there	is	a	
small	possibility	that	some	of	the	questions	may	lead	you	to	think	about	
certain	experiences	in	your	life	that	you	find	upsetting.		You	are	free	to	stop	
the	study	at	any	point.		At	the	end	of	the	study	if	you	would	like	to	talk	to	
someone	about	any	of	the	issues	covered	in	the	survey,	I	will	ensure	that	a	
member	of	staff	is	informed.	
	
Can	I	speak	to	someone	who	is	independent	of	the	study?	
Yes.	You	can	speak	to	Professor	Thomas	McMillan	at	the	University	of	
Glasgow	(Tel:	+44(0)	141	211	0354	or	thomas.mcmillan@glasgow.ac.uk).	
	
What	if	there	is	a	problem?	
If	you	have	a	concern	with	any	aspect	of	the	study,	please	speak	to	the	
researcher	who	will	do	their	best	to	assist	you.	To	contact	the	research	team	
please	call	0141	211	3922.	If	you	remain	unhappy	and	wish	to	complain	
formally,	you	can	do	this	through	NHS	Greater	
Glasgow	and	Clyde	Complaints	by	telephoning	0141	201	4500	
	
Thank	you	for	taking	the	time	to	read	this.
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Appendix	8	
	
	 	
	
Participant	Identification	Number:	
	
CONSENT	FORM		
(Version	3	–	20/03/2016)	
	
Title	of	Project:		Meta-cognition,	social	problem-solving	and	psychosis.	
	
	
Principal	Investigator:	Jaclyn	MacLeod,	Trainee	Clinical	Psychologist.	
Chief	Investigator:	Dr	Hamish	McLeod,	Programme	Director	for	Doctorate	in	Clinical	
Psychology	and	Senior	Lecturer,	University	of	Glasgow.	
Local	Lead	Investigators:	Dr	Emma	Drysdale,	Consultant	Clinical	Psychologist	(NHS	Greater	
Glasgow&	Clyde.	
	
										 																	Please	initial	
box	
	
	
1.	I	have	read	and	understand	the	Participant	Information	Sheet	dated....................	
(Version............)	for	the	above	study.	
	
2.	I	have	had	the	opportunity	to	consider	the	information,	ask	questions	and	have	had		
these	answered	satisfactorily.	
	
3.	I	understand	that	my	participation	is	voluntary	and	that	I	am	free	to	withdraw	
	at	any	time	without	giving	any	reason,	without	my	medical	care	or	legal	
	rights	being	affected.	
	
4.	I	understand	that	the	interview	will	be	recorded	and	transcribed,	and	that	
	following	transcription	the	original	recording	will	be	destroyed	and	all		
personal	information	will	be	removed	from	the	transcript.	
	
5.		I	understand	that	if	I	say	anything	that	makes	the	researcher	
concerned	about	my	safety	or	the	safety	of	another	person,		
this	information	may	be	passed	onto	a	relevant	third	party.	I	also	
understand	that	the	researcher	will	attempt	to	discuss	this	with	
me,	should	this	situation	arise.	
	
6.	I	understand	that	remarks	I	make	may	be	included	in	an	
anonymous	form	in	reports	about	this	research	(please	leave	
this	blank	if	you	do	not	consent	to	this).	
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7.	I	understand	that	the	relevant	sections	of	my	medical	notes	and	data	collected		
during	the	study	may	be	looked	at	by	individuals	from	Greater	Glasgow	and	Clyde	
NHS	and	the	University	of	Glasgow,	where	it	is	relevant	to	my	taking	part	in	this		
Research.		I	give	permission	for	these	individuals	to	access	my	records.	
	
8.	I	agree	to	take	part	in	the	above	study.		
	
	
	
	
	 	 	 	 	 	 	 	 	 	 	
Name	of	participant	 Date	 Signature	
	
	
	
	
	
	 	 	
Name	of	person	taking	consent	 	 Date
	 Signature	
	
	Participant’s	Identification	Number	for	this	study	
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Appendix	9	
	
	
MEPS	CODING	FRAMEWORK	FOR	NEW	SCENARIOS		
	
Read	through	participant’s	entire	response	to	evaluate	logic	and	consistency	displayed	in	
connecting	the	beginning	and	end.	
	
Each	scenario	is	scored	on	number	of	relevant	means.	
	
Categories	of	means	end	scored	is	not	only	tallied	but	also	placed	in	one	of	several	
categories	empirically	developed	for	each	story.	
	
Each	category	is	broad	enough	to	include	several	different	means,	which	are	similar,	but	
the	exact	form	can	differ	because	of	being	given	by	different	participants.	
	
Individual	means	
	
An	individual	‘means’	is	scored	for	each	discrete	step,	which	is	effective	in	enabling	the	
hero	of	the	story	to	reach	the	resolution	stage	or	to	overcome	an	obstacle	preventing	the	
hero	from	reaching	the	goal	in	the	story.	(Platt	and	Spivak,	1975).	
	
In	order	to	identify	individual	‘means’	a	list	of	categories	have	been	established	for	each	
new	scenario.		
	
The	following	categories	represent	discrete	steps	for	each	scenario,	each	category	
represents	a	distinct	type	of	action	that	might	be	taken	in	order	to	achieve	the	story	
ending,	that	is,	a	category	corresponds	to	a	discrete	step.		If	a	participant	suggests	multiple	
actions	belonging	to	a	single	category,	these	constitute	a	single	step	and	are	then	counted	
as	one	means.	
 
Have	a	discussion:	A	lot	participants	go	into	a	good	deal	of	detail	about	what	should	go	on	
within	the	context	of	the	discussion	and	it	is	felt	that	in	many	cases	too	much	would	be	lost	
by	counting	all	this	detail	as	a	single	mean.		
3	common	sub-categories	have	been	identified	into	which	it’s	useful	to	sort	details	
of	 a	 discussion:	 i)	 discuss	 problems;	 ii)	 discuss	 solutions;	 iii)	 express	 feelings.	 	 ‘Have	 a	
discussion’	 should	 be	 considered	 a	 super-ordinate	 category	 and	 counted	 as	 a	 discrete	
mean	in	its	own	right	only	when	none	of	the	sub-categories	are	present.	When	any	of	the	
sub-categories	 are	 present	 ‘have	 a	 discussion’	 is	 not	 counted	 as	 a	 separate	 mean,	 but	
each/any	of	the	sub-categories	present	are	counted	separately.	
	
E.g.	“She	should	definitely	speak	to	him.	Hopefully	that	will	work.”	
-	I	would	score	this	as	one	mean	(i.e.	‘have	a	discussion’)	
	
E.g.	“They	should	have	a	proper	talk	about	it.	They	should	talk	about	what	was	causing	the	
arguments	and	what	they	can	do	to	make	things	better	 in	the	future.	She	should	tell	him	
she	loves	him	too,	to	make	sure	he	knows.”	
-	 I	would	 score	 this	 as	 three	 separate	means	 (i.e.	 ‘discuss	 problems’,	 ‘discuss	 solutions’;	
‘express	feelings’.	I	would	not	count	‘have	a	discussion	as	a	discrete	mean	in	this	instance-	
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Introspection:	Platt	and	Spivak	say	“A	statement	of	introspection	is	not	sufficient	by	itself	
to	 be	 scored	 as	 a	 means,	 e.g.,	 use	 of	 the	 word	 “realise”	 is	 not	 adequate	 to	 assume	
introspection.	However,	 if	 the	hero	acts	upon	his	 introspection,	e.g.,	by	apologising,	 two	
means	should	be	scored	–	one	for	introspection	and	one	for	his	action.”	I’ve	generally	kept	
to	this.	
	
A	note	on	unsuccessful	means:	
	
Platt	 and	 Spivak	 are	 reasonably	 clear	 in	 stating	 that	means	 that	 do	 not	 contribute	 to	 a	
successful	 outcome	 should	 not	 be	 counted.	 I	 would	 be	 inclined	 to	 disagree.	 Very	 often	
participants	 using	 a	 story-telling	 style	 to	 answer	 the	 question	will	mention	 unsuccessful	
strategies	the	protagonist	tried	before	finding	a	solution.	I	think	mostly	they	do	this	to	be	
colourful	and	make	the	story	interesting,	but	often	these	‘unsuccessful’	strategies	are	good	
suggestions	 that	 in	 reality	might	 be	 effective	 and	 I	would	 be	 inclined	 to	 count	 these	 as	
distinct	means.	
	
Example:	
	
“Julie	sits	down	and	thinks	about	what	she	might	have	done	to	cause	her	friends	to	avoid	
her.	But	 she	can’t	 think	of	anything	so	she	asks	another	 friend	who	 isn’t	one	of	 the	ones	
avoiding	her	if	anyone’s	said	anything.	Her	friend	doesn’t	know	either	so	she	decides	to	go	
and	ask	them	directly.	They	tell	her	they	don’t	like	how	much	she’s	been	drinking	lately.	She	
says	she	didn’t	 realise	how	much	she	was	drinking,	but	 they’re	right	and	she	promises	 to	
cut	down.	They’re	happy	with	that	and	everything’s	fine.”	
-	Here	Julie	tries	two	strategies	–	‘introspection’	and	‘third	party’	–	but	they	are	
unsuccessful.	I	would	nonetheless	be	inclined	to	count	them.	The	rest	of	this	story	includes	
two	more	means	–	‘discuss	problem’	and	‘improve	self’	–	so	four	overall	
	
	
Scenario	1.5.		
	
You	are	having	problems	getting	along	with	someone	close	to	you	
The	story	ends	with	you	and	?	getting	along	better	
	
 
- Alter behaviour: This includes any efforts to improve competency, e.g. do his/her job 
better, be a better employee or colleague, or to curtail problem behaviour, e.g. “He should 
cut out the drink and stop letting it affect his work”. This is typically suggested before or 
instead of attempting to solve a particular problem, but rather as a general approach. 
 
- Ask for help or reason:  I would re-work this category as ‘have a discussion/meeting’, 
include the sub-categories outlined for ‘have a discussion’ in Problem 1 and apply in the 
same way. 
 
- Solve problem: This includes any action aimed at solving a problem between 
protagonist and boss that does not come under ‘alter behaviour’. 
 
- Follow advice: I think it’s rare that this would come up as distinct from ‘alter behaviour’ 
and ‘solve problem’.  
 
- Show motivation: Any behaviour aimed at showing enthusiasm for the job and 
willingness to work hard. This is subtly distinct from ‘alter behaviour’ whereby competency 
rather than motivation is the central feature. 
	 89	
 
- Have a discussion or meeting: As described above replace ‘ask for help or reason’ 
with ‘have a discussion or meeting’ and include three sub-categories: i) ‘discuss 
problems’, ii) ‘discuss solutions’ and iii) express feelings. 
 
- Request meeting: When participants elaborate the process of requesting a meeting this 
should count as a separate means in the same way that ‘establish contact’ does in 
problems 1 and 3. 
 
- Third party: Any suggestion that involves enlisting the help of a third party. This includes 
mediators, HR, colleagues or boss’s superiors.  
 
- Socialise with boss: This comes up a lot so I feel it warrants a category. Includes any 
effort to engage the boss on a personal level and get on better that way. 
 
This category may involve some extreme and probably ineffective but nonetheless 
relevant suggestions such as sleeping with the boss. 
  
- Introspection: As discussed previously 
 
C) COMMON NON-RELEVANT MEANS: 
 
• Leave job/get a new job 
 
 
 
Scenario	2.8		
You	are	worried	about	the	health	of	a	close	friend	or	relative	and	you	are	not	sure	what	to	
do.	The	story	ends	with	you	being	less	worried	about	your	close	friend/relative’s	health.	
Categories	
Introspection:	As	before,	in	addition	this	scenario	would	include	‘observing	the	individual	
to	see	if	suspicions	are	correct’.	
Speak	to	third	party:	This	can	include	professionals	or	other	friends	and	relatives.		Again	if	
participants	go	into	detail	and	say	they	would	talk	to	a	friend	first,	then	Google	and	then	go	
to	a	doctor	to	get	advice	this	would	be	scored	3	means;	get	more	information	for	self	or	
for	them.			
Discussion:	Ask	them	what	you	can	do	to	support	them,	tell	them	you	are	worried,	ask	
them	if	there	is	a	problem.	
Participants	go	into	details	about	different	things	they	can	do	that	would	help	them	feeling	
less	worried.		These	strategies	have	been	broken	down	into	the	following	categories.	
Contact:	This	can	include,	spend	time	with	them;	keep	in	regular	contact.	
Support:	Just	be	there	for	them;	encourage	them	to	see	a	professional,	offer	to	go	with	
them	to	doctor;	pray/meditate	or	chant	with	for	them.	
Again	all	of	the	above	categories	can	be	scored	with	sub-categories	within	as	people	often	
go	into	detail	of	the	different	things	that	they	would	do	within	each	of	those	categories.	
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Cognitive	restructuring:		Participants	often	talk	about	cognitive	strategies	to	help	them	
cope	with	the	situation.		An	example	would	include	‘worry	less	and	accept	it	is	out	of	my	
control’	this	would	be	scored	as	a	mean	step	when	it	is	processed	by	the	participant	after	
they	have	had	a	conversation	with	the	individual	or	other	friends/family.	
Non-relevant	means	
• Worry	less	accept	out	of	my	control	
• Observe	first	to	see	if	suspicions	correct	
• Send	a	card	
	
Limitations/discussion			
Can	be	ambiguous	as	does	not	state	how	good	a	friend	they	are	and	some	participants	
have	commented	on	this.	
Scenario	3.9	(new	scenario)	
Recently,	a	friend	has	been	repeatedly	letting	you	down.			The	story	ends	with	you	no	longer	
feeling	let	down.	
Categories	
	
Introspection:	As	before	
	
Discussion:	As	with	previous	scenarios	this	can	involve	much	detail	about	how	they	would	
tackle	the	problem	when	they	do	talk	to	the	friend.		The	details	are	then	scored	as	sub-
categories	and	1	means	is	scored	for	each	one.		Examples	are:	talk	to	friend,	confront	
friend,	seek	explanation,	tell	them	how	feel,	tell	them	been	missing	their	company,	look	
for	understanding	and	seek	a	solution.		
	
Cognitive	restructuring:	Participants	also	talk	about	changing	their	attitude	towards	the	
friend,	which	is	a	way	to	deal	with	something	that	you	may	have	no	control	over.	When	
this	is	stated,	after	having	a	conversation,	it	is	then	scored	as	a	mean	step.		This	can	also	
include	stop	trusting	them	and	try	to	be	more	flexible	with	them	or	just	let	it	go.	
	
Modifying	behavior:	Some	participants	talk	about	doing	something	nice	for	them	or	for	
both	of	them	to	do	something	nice	together.		It	is	difficult	to	categorise	these	strategies	
but	it	could	effectively	be	viewed	as	reaching	out	to	them	in	the	way	that	you	behave.		It	
is	therefore	accepted	as	a	means	step	as	perhaps	the	participant	feels	that	they	are	
doing	all	they	can	to	support	the	friendship.	
	
No	longer	be	their	friend:		When	language	similar	to	this	is	used	we	have	generally	scored	
it	as	a	means	step.		An	example	is	‘if	the	situation	does	not	change	then	I	would	no	longer	
be	their	friend’,	or	‘rely	on	other	friends’	
	
The	rationale	here	is	that	they	are	attempting	to	deal	with	the	situation,	which	is	in	
response	to	the	ending,	and	it	is	accepted	then	that	this	would	be	a	realistic	step	to	take.	
Importantly,	this	would	be	scored	as	an	non-effective	mean	when	not	backed	up	with	any	
other	problems	solving	strategies.	
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‘Take	a	step	back	and	wait	for	them	to	contact	you.	
	
Non-effective	Means	
• Try	to	please	them	more	
	
Limitations/discussion	
Perhaps	the	ending	is	wrong	with	this	scenario	as	it	is	easy	for	people	to	say	‘just	no	longer	
be	friends	with	them’	so	you	are	not	getting	a	true	reflection	from	them.		Despite	
emphasis	on	it	being	‘the	ideal	strategy’	this	seems	to	be	forgotten	by	participants.		The	
majority	of	participants	do	respond	in	details	it	could	be	related	to	their	mood.	
	
Scenario	4.10.		
You	have	been	really	worried	about	what	a	friend	thinks	about	you.		The	story	ends	with	
you	feeling	less	worried	about	what	your	friend	thinks	about	you.	
	
Introspection	
As	this	is	an	intrapersonal	scenario	it	was	felt	that	scoring	for	introspection	should	be	
different	to	that	of	previous	scenarios	(where	introspection	was	always	scored	one	means,	
regardless	of	whether	they	put	this	into	action).		It	was	agreed	that	if	an	individual	went	
onto	a	different	train	of	thought	during	introspection	then	that	would	score	a	second	
point.	Examples	include,	consider	things	from	the	other	person’s	perspective	and	watch	
your	friend’s	behaviour	when	they	are	around	you.	
‘Praying’	was	classified	as	a	form	of	introspection	in	this	scenario	(other	scenario’s	it	has	
been	scored	as	an	ineffective	mean).	
It	is	also	worthy	of	note	that	an	adequate	response	does	require	some	level	of	
introspection	first	
	
Avoidance:	Some	participants	use	avoidance	as	a	positive	step	to	take	in	order	to	gain	
perspective	on	the	situation.		However,	not	all	cases	of	avoidance	can	be	scored	as	1	
means	step;	some	participants	mention	it	just	to	avoid	the	situation,	as	a	way	to	deal	with	
it,	in	other	words	just	ignore	it.		It	was	agreed	that	ignoring	the	problem	completely	would	
then	not	be	counted	as	1	means	step.		The	rationale	here	is	that	avoiding	something	does	
not	mean	that	you	do	not	worry	about	it.		Indeed,	the	literature	on	coping	shows	us	that	
avoidance	coping	is	a	dysfunctional	form	of	coping.	
	
Cognitive	restructuring:	Participants	talk	about	changing	his	or	her	attitude	to	the	person,	
rationalising	this	as	‘not	everyone	can	like	you’	or	‘it	is	not	worth	being	upset	about	so	
ignore	it’.		We	felt	that	this	could	be	an	effective	means	step	but	would	score	low	on	
effectiveness.		It	is	reasonable	to	assume,	that	by	changing	your	attitude	to	a	situation	you	
have	no	control	over,	is	a	reasonable	way	to	cope	with	a	situation.		
Difficulties	arise	here	when	the	participant	does	not	back	up	their	statement	with	any	
rationale,	for	example:	‘just	ignore	what	others	think	of	you’;	‘it	does	not	matter	what	
other	people	think	of	me’	in	these	instances	those	statements	would	not	be	scored	as	a	
means	step.			
	
Discussion:	Can	include	talk	to	the	person	about	it;	discuss	anxieties;	talk	through	
problems;	seek	reassurance;	listen	to	friend;	apologise;	ask	if	done	anything	to	upset	them;	
seek	a	resolution;	probe	friend	discretely	to	ascertain	their	opinion	of	me;	change	
behaviour.	
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Speak	to	third	party:	talk	to	other	friends;	speak	to	a	profession	
Some	participants	talk	about	‘boosting	own	confidence’	or	building	up	my	self-esteem’.	
When	such	statements	are	given	as	a	strategy	it	is	important	that	obvious	steps	back	up	
these	strategies.		In	other	words	clear	statements	are	made	about	how	that	action	would	
help	you	feel	less	worried.		Otherwise	they	are	to	be	scored	as	a	non-effective	mean.	
	
Non-effective	means	
• Worry	for	a	while;	Cast	problem	to	back	of	mind;	Don’t	care	what	other	people	think;	
Relaxation	techniques;	Praying/chanting;	Be	kind	to	them	
	
	
b)	Scoring	effectiveness	
	
Part	2:	Scoring	Effectiveness	
	
2.1	Definition	of	Effectiveness:	
	
“Effectiveness	 was	 defined	 according	 to	 the	 definition	 of	 an	 effective	 problem	 solution	
given	by	D’Zurilla	and	Goldfried	(1971).	Following	this	definition	a	problem	solving-solving	
strategy	 is	 effective	 if	 it	 maximizes	 positive	 short-	 and	 long-term	 consequences	 and	
minimizes	 negative	 (short-	 and	 long-term)	 consequences,	 both	 personally	 and	 socially.”	
(From	Danielle’s	document)		
	
2.2	Likert	Scale:	
	
[The	 real	 challenge	 is	 remaining	 consistent.	 Overall,	 a	 good	 approach	 is	 scoring	 a	 large	
number	of	answers	given	by	different	participants	to	the	same	question,	in	one	sitting.	This	
gives	you	a	good	idea	of	what,	for	this	particular	question,	is	average,	what	is	exceptionally	
bad	and	what	is	exceptionally	good.]	
	
The	overall	effectiveness	of	each	strategy	was	rated	on	a	7-point	Likert-type	scale	ranging	
from	“1	-	not	at	all	effective”	to	“7	-	extremely	effective”.		
	
Start	by	reading	the	answer	fully	to	get	an	overall	sense	of	whether	the	suggested	strategy	
would	 be	 generally	 ineffective	 (will	 receive	 a	 score	 of	 1	 or	 2),	 somewhat	 to	moderately	
effective	(will	receive	a	score	of	3-5),	or	very	effective	(will	receive	a	score	of	6-7).	
	
In	order	to	decide	on	a	final	score	consider	how	effective	the	strategy	is	likely	to	be	in	the	
short	 and	 long	 term.	 Generally	 long-term	 success	 involves	 addressing	 the	 cause	 of	 the	
problem	 and	 taking	 steps	 to	 overcome	 it.	 Below	 is	 a	 general	 outline	 of	 the	 level	 of	
effectiveness	associated	with	each	point	on	the	Likert	scale.	
		
NB:	The	descriptions	given	are	less	appropriate	to	Problem	2	where	it	isn’t	so	much	a	case	
that	 something	 has	 gone	 wrong	 and	 needs	 to	 be	 fixed.	 The	 above	 definition	 of	
effectiveness	would	still	apply	in	this	case,	though.	
	
Point-by-point	breakdown	of	the	Likert	scale	
	
1	point:		
Unlikely	to	have	any	positive	effect	and/or	is	likely	to	have	significantly	negative	effect	
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-	Complete	inaction		
-	Aggressive,	offensive	or	destructive	behaviour		
	
2	points:		
Likely	to	have	a	limited	positive	effect	and/or	could	result	in	negative	consequences	
	
-	Minimal	action	
-	Manipulation		
-	Mild	aggression/telling	off		
	
3	points:	
Likely	 to	 have	 some	positive	 outcome,	 at	 least	 in	 the	 short-term,	 but	 unlikely	 to	 have	 a	
positive	long-term	effect	i.e.	fails	to	get	to	the	root	of	the	problem	
	
-	Talking	to	friends	without	any	detail	as	to	what	they	might	talk	about	
-	General/generic	positive	actions	that	do	not	specifically	address	the	cause	of	the	problem	
	
4	points:		
Likely	to	have	a	significantly	positive	outcome	in	the	short-term	and/or	begins	to	address	
long-term	 outcomes	 but	 is	 insufficient	 to	 achieve	 positive	 long-term	 effect;	 seeks	 to	
uncover	the	cause	of	the	problem	but	is	unlikely	to	overcome	the	cause		
	
-	Apologising	but	taking	no	further	action	
-	 Asking	 self,	 the	 other	 party	 or	 a	 third	 party	 about	 the	 cause	 of	 the	 problem,	 but	 not	
taking	steps	to	overcome	the	cause	
	
5	points:	
Likely	 to	 have	 at	 least	 some	 long-term	 success;	 uncovers	 the	 cause	 of	 the	 problem	and	
goes	some	way	to	overcoming	it;	or	problem	is	overcome,	but	little	or	no	detail	is	provided	
as	to	how	this	was/should	be	achieved	
	
-	Discussing	the	problem	and/or	possible	solutions	with	others	involved	
-	Discussing	the	problem	and	‘sorting	it’	without	any	specifics	on	how	to	‘sort	it’	
	
6	points:	
Likely	to	have	good	long-term	success;	Uncovers	the	cause	of	the	problem	and	takes	active	
steps	that	are	likely	succeed	in	overcoming	the	problem	
	
-	 Discussing	 the	 problem	 and/or	 possible	 solutions	 and	 taking	 action	 such	 as	 changing	
behaviour	
	
7	points:	
Very	likely	to	overcome	the	problem	fully	in	the	long-term;	Uncovers	the	cause	of	problem	
and	 takes	 (often	multiple)	active	 steps	 that	are	very	 likely	 to	 succeed	 in	overcoming	 the	
problem	
		
-	 Detailed	 answer	 working	 through	 from	 the	 beginning	 of	 the	 story	 to	 the	 ending,	
addressing	 the	 cause	 of	 the	 problem	 and	 suggesting	 sufficiently	 details	 descriptions	 of	
possible	solutions.	
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Appendix	10	
															Table	of	CTAM	scores	for	each	study	
 
	
	
	
 
 
 
 
 
 
 
 
 
Trial 
Sampl
e (max 
10) 
Allocation
s (max 16) 
Assessmen
t 
(max 32) 
Contro
l 
(max 
16) 
Analysi
s 
(max 
15) 
Treatment 
Descriptio
n (max 11) 
Total 
CTA
M 
(max 
100) 
Granhol
m et al. 
(2014) 
10 16 32 0 15 6 79 
Grant et 
al. 
(2012) 
 
10 16 29 16 15 11 97 
Karkvik 
et al. 
(2013) 
5 13 19 16 15 11 79 
Lecomte 
et al. 
(2008; 
2012) 
10 10 32 0 15 11 68 
Li et al. 
(2015) 10 16 32 0 15 11 84 
Lincoln 
et al. 
(2012) 
5 16 19 16 15 6 77 
Morrison 
et al. 
(2015) 
10 16 16 6 11 11 70 
Naeem et 
al. 
(2015) 
10 16 32 6 15 11 90 
